0001144204-18-028903.txt : 20180515 0001144204-18-028903.hdr.sgml : 20180515 20180515161851 ACCESSION NUMBER: 0001144204-18-028903 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 43 CONFORMED PERIOD OF REPORT: 20180331 FILED AS OF DATE: 20180515 DATE AS OF CHANGE: 20180515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOANALYTICAL SYSTEMS INC CENTRAL INDEX KEY: 0000720154 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 351345024 STATE OF INCORPORATION: IN FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-23357 FILM NUMBER: 18836764 BUSINESS ADDRESS: STREET 1: 2701 KENT AVE CITY: WEST LAFAYETT STATE: IN ZIP: 47906-1382 BUSINESS PHONE: 3174634527 MAIL ADDRESS: STREET 1: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 10-Q 1 tv493923_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2018

OR

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from ___________ to _____________.

Commission File Number 000-23357

BIOANALYTICAL SYSTEMS, INC.

(Exact name of the registrant as specified in its charter)

INDIANA

(State or other jurisdiction of incorporation or
organization)

35-1345024

(I.R.S. Employer Identification No.)

2701 KENT AVENUE

WEST LAFAYETTE, INDIANA

(Address of principal executive offices)

47906

(Zip code)

(765) 463-4527

(Registrant's telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES x NO ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer (Do not check if a smaller reporting company) ¨

Smaller Reporting Company x Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ¨ NO x

As of May 10, 2018, 8,245,320 of the registrant's common shares were outstanding.

TABLE OF CONTENTS

		Page
PART I	FINANCIAL INFORMATION

Item 1	Condensed Consolidated Financial Statements:
	Condensed Consolidated Balance Sheets as of March 31, 2018 (Unaudited) and September 30, 2017	3
	Condensed Consolidated Statements of Operations and Comprehensive Income for the Three and Six Months Ended March 31, 2018 and 2017 (Unaudited)	4
	Condensed Consolidated Statements of Cash Flows for the Six Months Ended March 31, 2018 and 2017 (Unaudited)	5
	Notes to Condensed Consolidated Financial Statements	6
Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	12
Item 3	Quantitative and Qualitative Disclosures about Market Risk	20
Item 4	Controls and Procedures	20

PART II	OTHER INFORMATION

Item 1A	Risk Factors	20
Item 6	Exhibits	21
	Signatures	22

BIOANALYTICAL SYSTEMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share amounts)

	March 31, 2018			September 30, 2017
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	672		$	434
Accounts receivable
Trade, net of allowance of $2,019 at March 31, 2018 and $2,404 at September 30, 2017		2,726			2,530
Unbilled revenues and other		410			615
Inventories, net		1,000			913
Prepaid expenses		742			814
Total current assets		5,550			5,306

Property and equipment, net		14,625			14,965
Lease rent receivable		102			87
Deferred tax asset		67			—
Goodwill		38			38
Other assets		18			21

Total assets	$	20,400		$	20,417

Liabilities and shareholders’ equity
Current liabilities:
Accounts payable	$	1,838		$	2,052
Restructuring liability		1,117			1,117
Accrued expenses		1,283			1,202
Customer advances		3,107			2,980
Income taxes payable		26			20
Current portion of capital lease obligation		132			128
Current portion of long-term debt		228			224
Total current liabilities		7,731			7,723
Capital lease obligation, less current portion		2			69
Long-term debt, less current portion, net of debt issuance costs		4,049			4,158
Total liabilities		11,782			11,950

Shareholders’ equity:
Preferred shares, authorized 1,000,000 shares, no par value: 1,035 Series A shares at $1,000 stated value issued and outstanding at March 31, 2018 and at September 30, 2017		1,035			1,035
Common shares, no par value:
Authorized 19,000,000 shares; 8,245,320 issued and outstanding at March 31, 2018 and 8,243,896 at September 30, 2017		2,023			2,023
Additional paid-in capital		21,516			21,446
Accumulated deficit		(15,956	)		(16,037	))
Total shareholders’ equity		8,618			8,467
Total liabilities and shareholders’ equity	$	20,400		$	20,417

The accompanying notes are an integral part of the condensed consolidated financial statements

BIOANALYTICAL SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE INCOME

(In thousands, except per share amounts)

(Unaudited)

	Three Months Ended March 31,						Six Months Ended March 31,
	2018			2017			2018			2017

Service revenue	$	5,030		$	4,962		$	9,555		$	10,226
Product revenue		914			1,397			1,766			2,307
Total revenue		5,944			6,359			11,321			12,533

Cost of service revenue		3,662			3,546			6,935			7,296
Cost of product revenue		542			770			1,065			1,335
Total cost of revenue		4,204			4,316			8,000			8,631

Gross profit		1,740			2,043			3,321			3,902
Operating expenses:
Selling		303			242			597			578
Research and development		149			110			288			214
General and administrative		1,178			1,136			2,315			2,461
Total operating expenses		1,630			1,488			3,200			3,253

Operating income		110			555			121			649

Interest expense		(48	)		(134	)		(100	)		(210	)
Other income		4			1			4			2
Net income before income taxes		66			422			25			441

Income taxes (benefit) expense		11			5			(56	)		7

Net income	$	55		$	417		$	81		$	434

Other comprehensive income:		—			8			—			29

Comprehensive income	$	55		$	425		$	81		$	463


Basic net income per share	$	0.01		$	0.05		$	0.01		$	0.05
Diluted net income per share	$	0.01		$	0.05		$	0.01		$	0.05

Weighted common shares outstanding:
Basic		8,245			8,148			8,245			8,128
Diluted		8,789			8,710			8,793			8,707

The accompanying notes are an integral part of the condensed consolidated financial statements.

BIOANALYTICAL SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Six Months Ended March 31,
	2018			2017

Operating activities:
Net income	$	81		$	434
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		782			860
Employee stock compensation expense		69			7
Provision for doubtful accounts		(4	)		—
Gain on disposal of property and equipment		(1	)		(6	)
Changes in operating assets and liabilities:
Accounts receivable		(3	)		(997	)
Inventories		(87	)		334
Income tax accruals		(61	)		3
Prepaid expenses and other assets		72			41
Accounts payable		(214	)		(962	)
Accrued expenses		81			198
Customer advances		127			649
Net cash provided by operating activities		842			561

Investing activities:
Capital expenditures		(433	)		(158	)
Proceeds from sale of equipment		2			6
Net cash used by investing activities		(431	)		(152	)

Financing activities:
Payments of long-term debt		(111	)		(327	)
Payments of debt issuance costs		—			(45	)
Payments on revolving line of credit		(5,085	)		(6,823	)
Borrowings on revolving line of credit		5,085			6,883
Proceeds from exercise of stock options		1			—
Payments on capital lease obligations		(63	)		(64	)
Net cash used by financing activities		(173	)		(376	)

Net increase in cash and cash equivalents		238			33
Cash and cash equivalents at beginning of period		434			386
Cash and cash equivalents at end of period	$	672		$	419

Supplemental disclosure of non-cash financing activities:
Cash paid for interest	$	94		$	139

The accompanying notes are an integral part of the condensed consolidated financial statements.

BIOANALYTICAL SYSTEMS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in thousands except per share data or as otherwise indicated)

(Unaudited)

DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION

Bioanalytical Systems, Inc. and its subsidiaries (“We,” “Our,” “Us,” the “Company” or “BASi”) engage in contract laboratory research services and other services related to pharmaceutical development. We also manufacture scientific instruments for life sciences research, which we sell with related software for use by pharmaceutical companies, universities, government research centers and medical research institutions. Our customers are located throughout the world.

We have prepared the accompanying unaudited interim condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles (“GAAP”), and therefore should be read in conjunction with our audited consolidated financial statements, and the notes thereto, included in the Company’s annual report on Form 10-K for the year ended September 30, 2017. Certain amounts in the fiscal 2017 consolidated financial statements have been reclassified to conform to the fiscal 2018 presentation without affecting previously reported net income or stockholders’ equity. In the opinion of management, the condensed consolidated financial statements for the three and six months ended March 31, 2018 and 2017 include all adjustments which are necessary for a fair presentation of the results of the interim periods and of our financial position at March 31, 2018. The results of operations for the three and six months ended March 31, 2018 may not be indicative of the results for the year ending September 30, 2018.

STOCK-BASED COMPENSATION

The Company’s 2008 Stock Option Plan (“the Plan”) is used to promote our long-term interests by providing a means of attracting and retaining officers, directors and key employees and aligning their interests with those of our shareholders. The Plan is described more fully in Note 9 in the Notes to the Consolidated Financial Statements in our Form 10-K for the fiscal year ended September 30, 2017. All options granted under the Plan had an exercise price equal to the market value of the underlying common shares on the date of grant. We expense the estimated fair value of stock options over the vesting periods of the grants. We recognize expense for awards subject to graded vesting using the straight-line attribution method, reduced for estimated forfeitures. Forfeitures are revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates and an adjustment is recognized at that time. Stock based compensation expense for the three and six months ended March 31, 2018 was $35 and $69, respectively. Stock based compensation expense for the three and six months ended March 31, 2017 was $(3) and $7, respectively. The negative expense in the three month period ending March 31, 2017 was due to the forfeiture of options related to our former Chief Executive Officer.

In March 2018, our shareholders approved the amendment and restatement of the Plan in the form of the Amended and Restated 2018 Equity Incentive Plan (the “Equity Plan”) and future equity awards will be granted from the Equity Plan. Future common shares will be granted from the 2018 Equity Incentive Plan. The purpose of the Equity Plan is to promote our long-term interests by providing a means of attracting and retaining officers, directors and key employees. The maximum number of common shares that may be granted under the Equity Plan is 700 shares.

A summary of our stock option activity for the six months ended March 31, 2018 is as follows (in thousands except for share prices):

	Options (shares)			Weighted- Average Exercise Price		Weighted- Average Grant Date Fair Value

Outstanding - October 1, 2017		140		$	1.91	$	1.45
Exercised		(2	)	$	1.40	$	1.15
Granted		198		$	1.94	$	1.52
Forfeited		(13	)	$	4.46
Outstanding - March 31, 2018		323		$	1.83	$	1.45

The weighted-average assumptions used to compute the fair value of the options granted in the six months ended March 31, 2018 were as follows:

Risk-free interest rate	2.31	%
Dividend yield	0.00	%
Volatility of the expected market price of the Company's common shares	83.70	%
Expected life of the options (years)	8.0

As of March 31, 2018, our total unrecognized compensation cost related to non-vested stock options was $250 and is expected to be recognized over a weighted-average service period of 1.4 years.

INCOME (LOSS) PER SHARE

We compute basic income per share using the weighted average number of common shares outstanding. The Company has two categories of dilutive potential common shares: Series A preferred shares issued in May 2011 in connection with our registered direct offering and shares issuable upon exercise of options. We compute diluted earnings per share using the if-converted method for preferred stock and the treasury stock method for stock options, respectively.

The following table reconciles our computation of basic income per share to diluted income per share:

	Three Months Ended March 31,				Six Months Ended March 31,
	2018		2017		2018		2017
Basic net income per share:
Net income applicable to common shareholders	$	55	$	417	$	81	$	434
Weighted average common shares outstanding		8,245		8,148		8,245		8,128
Basic net income per share	$	0.01	$	0.05	$	0.01	$	0.05
Diluted net income per share:
Diluted net income applicable to common shareholders	$	55	$	417	$	81	$	434

Weighted average common shares outstanding		8,245		8,148		8,245		8,128
Plus: Incremental shares from assumed conversions:
Series A preferred shares		518		554		518		573
Dilutive stock options/shares		26		8		30		6
Diluted weighted average common shares outstanding		8,789		8,710		8,793		8,707
Diluted net income per share	$	0.01	$	0.05	$	0.01	$	0.05

INVENTORIES

Inventories consisted of the following:

	March 31, 2018			September 30, 2017

Raw materials	$	797		$	761
Work in progress		185			135
Finished goods		244			228
	$	1,226		$	1,124
Obsolescence reserve		(226	)		(211	)
	$	1,000		$	913

SEGMENT INFORMATION

We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to the Consolidated Financial Statements in our annual report on Form 10-K for the fiscal year ended September 30, 2017.

	Three Months Ended March 31,						Six Months Ended March 31,
	2018			2017			2018			2017

Revenue:
Service	$	5,030		$	4,962		$	9,555		$	10,226
Product		914			1,397			1,766			2,307
	$	5,944		$	6,359		$	11,321		$	12,533

Operating Income
Service	$	244		$	445		$	426		$	739
Product		(134	)		110			(305	)		(90	)
	$	110		$	555		$	121		$	649

Interest expense		(48	)		(134	)		(100	)		(210	)
Other income		4			1			4			2
Income before income taxes	$	66		$	422		$	25		$	441

INCOME TAXES

We use the asset and liability method of accounting for income taxes. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. We recognize the effect on deferred tax assets and liabilities of a change in tax rates in income in the period that includes the enactment date. We record valuation allowances based on a determination of the expected realization of tax assets.

On December 22, 2017, the United States (“U.S.”) enacted significant changes to the U.S. tax law following the passage and signing of H.R.1, “An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018” (the “Tax Act”) (previously known as “The Tax Cuts and Jobs Act”). The Tax Act included significant changes to existing tax law, including a permanent reduction to the U.S. federal corporate income tax rate from 35% to 21%.

Accordingly, the Company’s income tax provision for the three and six months ended March 31, 2018 reflects the current year impacts of the U.S. Tax Act on the estimated annual effective tax rate. The Tax Act reduces the U.S. federal corporate tax rate from 35% to 21%. The impact from the permanent reduction to the U.S. federal corporate income tax rate from 35% to 21% is effective January 1, 2018 (the “Effective Date”). When a U.S. federal tax rate change occurs during a fiscal year, taxpayers are required to compute a weighted daily average rate for the fiscal year of enactment and as a result the Company calculated a U.S. federal statutory income tax rate of 24.5% for the current fiscal year ending September 30, 2018.

The difference between the newly enacted federal statutory rate of 24.5% and our effective rate of (224.0)% is due to changes in our valuation allowance on our net deferred tax assets along with realizing the deferred tax asset associated with the AMT credit carry-forward. The impact of the newly enacted federal statutory rate as a result of the Tax Act to the net deferred tax assets is a provisional amount of approximately a $1,600 decrease with any offsetting decrease to the valuation allowance. The amount is provisional because the final number cannot be calculated until the underlying timing differences are known rather than estimated.

We recognize the tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. We measure the amount of the accrual for which an exposure exists as the largest amount of benefit determined on a cumulative probability basis that we believe is more likely than not to be realized upon ultimate settlement of the position.

At March 31, 2018 and September 30, 2017, we had a $27 and $16 liability, respectively, for uncertain income tax positions.

We record interest and penalties accrued in relation to uncertain income tax positions as a component of income tax expense. Any changes in the liability for uncertain tax positions would impact our effective tax rate. We do not expect the total amount of unrecognized tax benefits to significantly change in the next twelve months.

We file income tax returns in the U.S. and several U.S. States. We remain subject to examination by taxing authorities in the jurisdictions in which we have filed returns for years after 2012.

DEBT

Credit Facility

On June 23, 2017, we entered into a Credit Agreement (the “Credit Agreement”) with First Internet Bank of Indiana (“FIB”). The Credit Agreement includes both a term loan and a revolving line of credit and is secured by mortgages on our facilities and personal property in West Lafayette and Evansville, Indiana. We used the proceeds from the term loan to satisfy our indebtedness with Huntington Bank described below and terminated the related interest rate swap.

The term loan for $4,500 bears interest at a fixed rate of 3.99%, with monthly principal and interest payments of approximately $33. The term loan matures in June 2022. The balance on the term loan at March 31, 2018 was $4,335. The revolving line of credit for up to $2,000 matures in June 2019 and bears interest at the Prime Rate (generally defined as the highest rate identified as the “Prime Rate” in The Wall Street Journal “Money Rates” column on the date the interest rate is to be determined, or if that date is not a publication date, on the publication date immediately preceding) less Twenty-five (25) Basis Points (0.25%). The balance on the revolving line of credit at March 31, 2018 and September 30, 2017, was $0. We must pay accrued and unpaid interest on the outstanding balance under the credit line on a monthly basis.

The Credit Agreement contains various restrictive covenants, including restrictions on the Company's ability to dispose of assets, make acquisitions or investments, incur debt or liens, make distributions to shareholders or repurchase outstanding stock, enter into related party transactions and make capital expenditures, other than upon satisfaction of the conditions set forth in the Credit Agreement. The Credit Agreement also requires us to maintain (i) a minimum debt service coverage ratio of not less than 1.25 to 1.0 and (ii) a debt to equity ratio of not greater than 2.50 to 1.00 until maturity. Upon an event of default, which includes certain customary events such as, among other things, a failure to make required payments when due, a failure to comply with covenants, certain bankruptcy and insolvency events, and defaults under other material indebtedness, FIB may cease advancing funds, increase the interest rate on outstanding balances, accelerate amounts outstanding, terminate the agreement and foreclose on all collateral.

We incurred $69 of costs in June 2017 related to the Credit Agreement that was partially amortized in the second half of fiscal 2017 and the first and second quarters of fiscal 2018 with the remainder to be amortized through June 2022. For the three and six months ended March 31, 2018, we amortized $4 and $7, respectively, into interest expense on the condensed consolidated statements of operations and comprehensive income. For the three and six months ended March 31, 2017, we amortized $82 and $103, respectively, into interest expense on the condensed consolidated statements of operations and comprehensive income. These noncash charges are included in depreciation and amortization on the consolidated statements of cash flows. As of March 31, 2018 and September 30, 2017, the unamortized portion of debt issuance costs related to our credit facility was $57 and $64, respectively, and was included in Long-term Debt, less current portion on the condensed consolidated balance sheets.

Former Credit Facility

On May 14, 2014, we entered into a Credit Agreement with Huntington Bank, which was subsequently amended on May 14, 2015 (“Agreement”). The Agreement included both a term loan and a revolving loan and was secured by mortgages on our facilities in West Lafayette and Evansville, Indiana and liens on our personal property. As of December 31, 2015, we were not in compliance with certain financial covenants of the Agreement, and during fiscal 2016 and most of the first nine months of fiscal 2017 we operated either in default of, or under forbearance arrangements with respect to, the Agreement.

Under a series of forbearance arrangements, Huntington Bank agreed during the relevant forbearance periods to forbear from exercising its rights and remedies under the Agreement and from terminating the Company’s related swap agreement with respect to the Company’s non-compliance with applicable financial covenants under the Agreement and to continue to make advances under the Agreement.

In exchange for Huntington Bank’s agreement to forbear from exercising its rights and remedies under the Agreement, the Company agreed to, among other things: (i) amend the maturity dates for the term and revolving loans under the Agreement (the last such amendment to July 31, 2017), (ii) take commercially reasonable efforts to obtain funds sufficient to repay the indebtedness in full upon the expiration of the forbearance periods, (iii) provide to Huntington Bank certain cash flow forecasts and other financial information, (iv) comply with a minimum cash flow covenant, (v) engage the services of a financial consultant and cause the financial consultant to provide Huntington Bank such information regarding its efforts as reasonably requested, and (vi) pay to Huntington Bank certain fees, including a forbearance fee, $27 of which was paid at the execution of the last forbearance agreement and an additional $100 was paid in June 2017.

We incurred a total of $56 of costs related to certain of our forbearance arrangements that was amortized in the first, second and third quarters of fiscal 2017.

Former Interest Rate Swap

We entered into an interest rate swap agreement with respect to the loans with Huntington Bank to fix the interest rate with respect to 60% of the value of the term loan at approximately 5.0%. We entered into this interest rate swap agreement to hedge interest rate risk of the related debt obligation and not to speculate on interest rates. The changes in the fair value of the interest rate swap were recorded in Accumulated Other Comprehensive Income to the extent effective. The interest rate swap was terminated as of June 23, 2017 in connection with the satisfaction of our indebtedness to Huntington Bank and the balance was reduced to zero.

ACCRUED EXPENSES

As part of a fiscal 2012 restructuring, we accrued for lease payments at the cease use date for our United Kingdom facility and have considered free rent, sublease rentals and the number of days it would take to restore the space to its original condition prior to our improvements. Based on these matters, we have a $1,000 reserve for lease related costs. Additionally, we accrued $117 for legal and professional fees and other costs to remove improvements previously made to the facility. At March 31, 2018 and September 30, 2017, respectively, we had $1,117 reserved for the liability. The reserve is classified as a current liability on the Consolidated Balance Sheets.

NEW ACCOUNTING PRONOUNCEMENTS

Effective October 1, 2018, the Company will be required to adopt the new guidance of ASC Topic 606, Revenue from Contracts with Customers (Topic 606), which will supersede the revenue recognition requirements in ASC Topic 605, Revenue Recognition. Topic 606 requires the Company to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The new guidance requires the Company to apply the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, the Company satisfies a performance obligation. The Company will be required to adopt Topic 606 either on a full retrospective basis to each prior reporting period presented or on a modified retrospective basis with the cumulative effect of initially applying the new guidance recognized at the date of initial application. If the Company elects the modified retrospective approach, it will be required to provide additional disclosures of the amount by which each financial statement line item is affected in the current reporting period, as compared to the guidance that was in effect before the change, and an explanation of the reasons for significant changes. With the help of external consultants, the Company is in the process of assessing the impact of the new guidance on its consolidated financial statements.

In February 2016, the FASB issued updated guidance on leases which, for operating leases, requires a lessee to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, in its balance sheet. The standard also requires a lessee to recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term, on a generally straight-line basis. The guidance is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, with earlier application permitted. We are currently evaluating the effects of adoption and have not yet determined the impact the revised guidance will have on our consolidated financial statements and related disclosures.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), which addresses eight specific cash flow issues and is intended to reduce diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance is effective for interim and annual periods beginning after December 15, 2017, and early adoption is permitted. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

In January 2017, the FASB issued ASU 2017-01, Business Combinations – Clarifying the definition of a business (Topic 805). This ASU clarifies the definition of a business with the objective of providing a more robust framework to evaluate whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The guidance will be effective for fiscal years beginning after December 15, 2017, including interim periods within that fiscal year, with early adoption permitted. The amendments are to be applied prospectively to business combinations that occur after the effective date.

In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment. ASU 2017-04 simplifies the accounting for goodwill impairments by eliminating Step 2 from the goodwill impairment test. Under the previous guidance an impairment of goodwill exists when the carrying amount of goodwill exceeds its implied fair value, whereas under the new guidance a goodwill impairment loss would be recognized if the carrying amount of the reporting unit exceeds its fair value, limited to the total amount of goodwill allocated to that reporting unit. The ASU is effective for annual and any interim impairment tests for periods beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In addition to the historical information contained herein, this report contains statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Those statements appear in a number of places in this report and may include, but are not limited to, statements regarding our intent, belief or current expectations with respect to (i) our strategic plans; (ii) trends in the demand for our products and services; (iii) trends in the industries that consume our products and services; (iv) our ability to develop new products and services; (v) our ability to make capital expenditures and finance operations; (vi) global economic conditions, especially as they impact our markets; (vii) our cash position; (viii) our ability to integrate a new sales and marketing team; (ix) our ability to service our outstanding indebtedness and (x) our expectations regarding the volume of new bookings, pricing, gross profit margins and liquidity. Readers are cautioned that forward-looking statements are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of various factors, many of which are beyond our control.

In addition, we have based these forward-looking statements on our current expectations and projections about future events. Although we believe that the assumptions on which the forward-looking statements contained herein are based are reasonable, actual events may differ from those assumptions, and as a result, the forward-looking statements based upon those assumptions may not accurately project future events. The following discussion and analysis should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included or incorporated by reference elsewhere in this report. Risks and uncertainties that may impact the forward-looking statements in this report include, but are not limited to, those discussed in Item 1A, Risk Factors contained in our annual report on Form 10-K for the fiscal year ended September 30, 2017. We do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise.

Amounts in this Item 2 are in thousands, unless otherwise indicated.

Business Overview

We are a contract research organization providing drug discovery and development services. Our customers and partners include pharmaceutical, biotechnology, academic and governmental organizations. We apply innovative technologies and products and a commitment to quality to help customers and partners accelerate the development of safe and effective therapeutics and maximize the returns on their research and development investments. We offer an efficient, variable-cost alternative to our customers' internal product development programs. Outsourcing development work to reduce overhead and speed drug approvals through the Food and Drug Administration ("FDA") is an established alternative to in-house pharmaceutical development. We derive our revenues from sales of our research services and drug development tools, both of which are focused on determining drug safety and efficacy. The Company has been involved in the research of drugs to treat numerous therapeutic areas for over 40 years.

We support the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. Our scientists have the skills in analytical instrumentation development, chemistry, computer software development, physiology, medicine, analytical chemistry and toxicology to make the services and products we provide increasingly valuable to our current and potential customers. Our principal customers are scientists engaged in analytical chemistry, drug safety evaluation, clinical trials, drug metabolism studies, pharmacokinetics and basic research at many of the small start-up biotechnology companies and the largest global pharmaceutical companies.

Our business is largely dependent on the level of pharmaceutical and biotechnology companies' efforts in new drug discovery and approval. Our contract research services segment is a direct beneficiary of these efforts, through outsourcing by these companies of research work. Our products segment is an indirect beneficiary of these efforts, as increased drug development leads to capital expansion, providing opportunities to sell the equipment we produce and the consumable supplies we provide that support our products.

Developments within the industries we serve have a direct, and sometimes material, impact on our operations. Currently, many large pharmaceutical companies have major "block-buster" drugs that are nearing the end of their patent protections. This puts significant pressure on these companies both to develop new drugs with large market appeal, and to re-evaluate their cost structures and the time-to-market of their products. Contract research organizations ("CROs") have benefited from these developments, as the pharmaceutical industry has turned to out-sourcing to both reduce fixed costs and to increase the speed of research and data development necessary for new drug applications. The number of significant drugs that have reached or are nearing the end of their patent protection has also benefited the generic drug industry. Generic drug companies provide a significant source of new business for CROs as they develop, test and manufacture their generic compounds.

We also believe that the development of innovative new drugs is going through an evolution, evidenced by the significant reduction of expenditures on research and development at several major international pharmaceutical companies, accompanied by increases in outsourcing and investments in smaller start-up companies that are performing the early development work on new compounds. Many of these smaller companies are funded by either venture capital or pharmaceutical investment, or both, and generally do not build internal staffs that possess the extensive scientific and regulatory capabilities to perform the various activities necessary to progress a drug candidate to the filing of an Investigative New Drug application with the FDA.

A significant portion of innovation in the pharmaceutical industry is now being driven by biotech and small, venture capital funded drug development companies. Many of these companies are "single-molecule" entities, whose success depends on one innovative compound. While several biotech companies have reached the status of major pharmaceuticals, the industry is still characterized by smaller entities. These developmental companies generally do not have the resources to perform much of the research within their organizations, and are therefore dependent on the CRO industry for both their research and for guidance in preparing their FDA submissions. These companies have provided significant new opportunities for the CRO industry, including us. They do, however, provide challenges in selling, as they frequently have only one product in development, which causes CROs to be unable to develop a flow of projects from a single company. These companies may expend all their available funds and cease operations prior to fully developing a product. Additionally, the funding of these companies is subject to investment market fluctuations, which changes as the risk profiles and appetite of investors change.

While continuing to maintain and develop our relationships with large pharmaceutical companies, we intend to aggressively promote our services to developing businesses, which will require us to expand our existing capabilities to provide services early in the drug development process, and to consult with customers on regulatory strategy and compliance leading to their FDA filings. Our Enhanced Drug Discovery services, part of this strategy, utilizes our proprietary Culex® technology to provide early experiments in our laboratories that previously would have been conducted in the sponsor’s facilities. As we move forward, we must balance the demands of the large pharmaceutical companies with the personal touch needed by smaller biotechnology companies to develop a competitive advantage. We intend to accomplish this through the use of and expanding upon our existing project management skills, strategic partnerships and relationship management.

Research services are capital intensive. The investment in equipment and facilities to serve our markets is substantial and continuing. Rapid changes in automation, precision, speed and technologies necessitate a constant investment in equipment and software to meet market demands. Market opportunities may also prompt investment in upkeep or expansion of our facilities. For example, in November 2017 we announced plans to expand our toxicology facility in Mt. Vernon, Indiana, near Evansville. We are also impacted by the heightened regulatory environment and the need to improve our business infrastructure to support our operations, which will necessitate additional capital investment. Our ability to generate capital to reinvest in our capabilities through operations and to obtain additional capital if and as needed through financial transactions, is critical to our success. Sustained growth will require additional investment in future periods. Continued positive cash flow and access to capital will be important to our ability to make such investments.

Executive Summary

Our revenues are dependent on a relatively small number of industries and customers. In the first six months of fiscal 2018, we experienced a 6.6% decrease in revenues in our Services segment and a 23.5% decrease in revenues for our Products segment as compared to the comparable period of fiscal 2017. Our Services revenue was negatively impacted by an unfavorable study mix for preclinical services and fewer samples to assay for bioanalytical analysis. These negative factors were partially offset by an increase in the number of studies for pharmaceutical analysis as well as our continued efforts to collect archive revenues in fiscal 2018. The revenue decline in our Products segment was mainly due to a decline in sales of our Culex automated in vivo sampling systems as compared to the first six months of fiscal 2017 partially offset by an increase in analytical instruments sales.

We review various metrics to evaluate our financial performance, including revenue, margins and earnings. In the first six months of fiscal 2018, total revenues decreased 9.7%, gross profit decreased 15.0% and operating expenses were lower by 1.6% as compared to same period in fiscal 2017. The decreased revenues and margins contributed to the lower reported operating income of $121 for the first six months of fiscal 2018 compared to operating income of $649 for the first six months of fiscal 2017. For a detailed discussion of our revenue, margins, earnings and other financial results for the three and six months ended March 31, 2018, see “Results of Operations” below.

As of March 31, 2018, we had $672 of cash and cash equivalents as compared to $434 of cash and cash equivalents at the end of fiscal 2017. In the first six months of fiscal 2018, we generated $842 in cash from operations as compared to $561 in the same period in fiscal 2017. Total capital expenditures increased in the first six months of fiscal 2018 to $433 from $158 in the first six months of fiscal 2017. In addition, accounts payable decreased by $214 and customer advances increased $127 compared to the prior fiscal year. We had a zero balance on our line of credit as of March 31, 2018.

We believe our fiscal 2018 first half financial results do not fully reflect all our efforts toward implementing key management initiatives, and we remain focused on executing those initiatives aimed at growing revenue, reducing costs and generating additional cash flow. We further believe that our Credit Agreement with First Internet Bank provides an important baseline source of liquidity to continue to implement relevant initiatives. In fiscal 2017, we welcomed the Company’s founder as a scientific advisor to management and benefit from his market presence and scientific knowledge. We continue to focus on marketing efforts to improve our message to customers and increase our visibility in the marketplace. We significantly reduced our employee turnover in fiscal 2017 and the first half of fiscal 2018 and began investing in developing complementary services and evaluating expansion and growth initiatives. We continue to build on these accomplishments in fiscal 2018 in order to grow our business and recruit and retain talent.

During fiscal 2018, we intend to continue to increase our investment in Products research and development in order to upgrade current products and to identify potential new products. We also intend to further develop and expand our relationships with distributors and resellers to boost sales in our Products business. We anticipate adding additional partnerships with companies similar to our current partners, Joanneum Research and PalmSens, to expand our Product offerings. Further, we have added key talent to help drive sales and development of our Products and to solidify relationships with our customers and prospective partners. We believe these measures will prepare us for growth in the long term.

In our Services segment, we are investing in laboratory equipment to add efficiencies and capabilities in areas of possible growth. We also plan to invest in the recruitment of additional talent and equipment upgrades in order to expand our discovery services capabilities. Further, we continue to explore avenues through which to expand service offerings to meet customer demand. Consistent with that aim, in November 2017, we announced plans to expand our toxicology facility in Mt. Vernon, Indiana, near Evansville. Additionally, we are recruiting talent to bolster staffing for our bioequivalence capabilities and service offering. Finally, we will continue the practice of charging for archive services as an additional revenue stream.

Our long-term strategic objective remains to maximize the Company’s intrinsic value per share. In order to achieve that end, we will focus on, among other items, productivity, generating free cash flow, and the strategies and initiatives mentioned above.

Results of Operations

The following table summarizes our condensed consolidated statement of operations as a percentage of total revenues for the periods shown:

	Three Months Ended March 31,						Six Months Ended March 31,
	2018			2017			2018			2017

Service revenue		84.6	%		78.0	%		84.4	%		81.6	%
Product revenue		15.4			22.0			15.6			18.4
Total revenue		100.0			100.0			100.0			100.0

Cost of Service revenue *(a)*		72.8			71.5			72.6			71.3
Cost of Product revenue *(a)*		59.3			55.1			60.3			57.9
Total cost of revenue		70.7			67.9			70.7			68.9

Gross profit		29.3			32.1			29.3			31.1

Total operating expenses		27.4			23.4			28.3			26.0

Operating income		1.9			8.7			1.0			5.1

Other income (expense)		(0.7	)		(2.1	)		(0.8	)		(1.7	)

Income before income taxes		1.2			6.6			0.2			3.4

Income tax (benefit) expense		0.2			0.1			(0.6	)		0.1

Net Income		1.0	%		6.5	%		0.8	%		3.3	%

(a)

Percentage of service and product revenues, respectively

Three Months Ended March 31, 2018 Compared to Three Months Ended March 31, 2017

Service and Product Revenues

Revenues for the quarter ended March 31, 2018 decreased 6.5% to $5,944 compared to $6,359 for the same period last fiscal year.

Our Service revenue increased 1.4% to $5,030 in the second quarter of fiscal 2018 compared to $4,962 for the comparable prior-year period. Preclinical services revenues increased $207 due to a more favorable mix of studies in the second quarter of fiscal 2018. Other laboratory services revenues were negatively impacted by lower discovery services, which impact was partially offset by higher pharmaceutical analysis revenues in the second quarter of fiscal 2018 versus the comparable period in fiscal 2017. Archive revenue added $130 to Other laboratory services revenue in the second quarter of fiscal 2018, as compared to $228 in the second quarter of fiscal 2017. Bioanalytical analysis revenues remained steady when compared to the comparable prior-year period.

	Three Months Ended March 31,
	2018		2017		Change			%
Bioanalytical analysis	$	1,244	$	1,245	$	(1	)		(0.1	)%
Preclinical services		3,301		3,094		207			6.7	%
Other laboratory services		485		623		(138	)		(22.2	)%
	$	5,030	$	4,962	$	68

Sales in our Products segment decreased 34.6% in the second quarter of fiscal 2018 to $914 from $1,397 in the same period of the prior fiscal year. The majority of the decrease stems from a decline in sales of our Culex automated in vivo sampling systems due to a large order shipped in the second quarter of fiscal 2017 that did not repeat. This factor was partially offset by an increase in analytical instruments revenues.

	Three Months Ended March 31,
	2018		2017		Change			%
Culex, in-vivo sampling systems	$	410	$	883	$	(473	)		(53.6	)%
Analytical instruments		355		323		32			9.9	%
Other instruments		149		191		(42	)		(22.0	)%
	$	914	$	1,397	$	(483	)

Cost of Revenues

Cost of revenues for the second quarter of fiscal 2018 was $4,204 or 70.7% of revenue, compared to $4,316, or 67.9% of revenue for the comparable prior-year period.

Cost of Service revenue as a percentage of Service revenue increased to 72.8% during the second quarter of fiscal 2018 from 71.5% in the comparable period in fiscal 2017. The principal cause of this increase was the decline in archive revenues, which carry higher margins.

Cost of Products revenue as a percentage of Products revenue in the second quarter of fiscal 2018 increased to 59.3% from 55.1% in the comparable prior-year period. This increase is mainly due to the mix of product sales during the second quarter of fiscal 2018, principally lower sales of the Culex automated in vivo sampling systems.

Operating Expenses

Selling expenses for the three months ended March 31, 2018 increased 25.2% to $303 from $242 for the comparable period in fiscal 2017. This increase is mainly due to higher salaries and benefits from the addition of marketing personnel in late fiscal 2017 plus slightly higher travel expenses in the second quarter of fiscal 2018 as compared to the prior-year period.

Research and development expenses for the second quarter of fiscal 2018 increased 35.5% over the comparable period last fiscal year to $149 from $110. The increase was primarily due to higher consulting expenses and costs for operating supplies related to product development.

General and administrative expenses for the second quarter of fiscal 2018 increased 3.7% to $1,178 from $1,136 for the comparable prior-year period. The principal reasons for the increase included employee search fees incurred in the second quarter of fiscal 2018 and higher stock option expense attributable to grants of options to our directors and certain of our employees in October 2017.

Other Income (Expense)

Other expense for the second quarter of fiscal 2018 was $44, as compared to other expense of $133 for the second quarter of fiscal 2017. The primary reason for the change in expense was the decrease in interest expense under our new credit agreement with First Internet Bank, as described below.

Income Taxes

Our effective tax rate for the three months ended March 31, 2018 and 2017 was 16.7% and 1.2%, respectively. The current year expense primarily relates to alternative minimum taxes and state taxes.

Net Income

As a result of the factors described above, net income for the quarter ended March 31, 2018 amounted to $55, compared to net income of $417 in the comparable fiscal 2017 period.

Six Months Ended March 31, 2018 Compared to Six Months Ended March 31, 2017

Service and Product Revenues

Revenues for the six months ended March 31, 2018 decreased 9.7% to $11,321 as compared to $12,533 for the same period last fiscal year.

Our Service revenue decreased 6.6% to $9,555 in the first six months of fiscal 2018 compared to $10,226 for the comparable prior-year period. Preclinical services revenues decreased due to an unfavorable mix of studies in the first quarter of fiscal 2018 as compared to the comparable prior-year period, partially offset by a more favorable mix in the second quarter of fiscal 2018. Other laboratory services revenues were negatively impacted by lower discovery services, which were partially offset by higher pharmaceutical analysis revenues in the first six months of fiscal 2018 versus the comparable period in fiscal 2017. Archive revenue added $190 to Other laboratory services revenue in the first six months of fiscal 2018 compared to $237 in the comparable period in fiscal 2017. Bioanalytical analysis revenues decreased due to fewer samples received and analyzed in the first six months of fiscal 2018 in addition to a mix favoring method development and validation projects during this time period, which generate lower revenue but involve more dedicated resources.

	Six Months Ended March 31,
	2018		2017		Change			%
Bioanalytical analysis	$	2,276	$	2,560	$	(284	)		(11.1	)%
Preclinical services		6,352		6,646		(294	)		(4.4	)%
Other laboratory services		927		1,020		(93	)		(9.1	)%
	$	9,555	$	10,226	$	(671	)

Sales in our Product segment decreased 23.5% in the first six months of fiscal 2018 from $2,307 to $1,766 when compared to the same period in the prior fiscal year. The majority of the decrease stems from lower sales of our Culex automated in vivo sampling instruments in the first six months of fiscal 2018, partially offset by an increase in sales of our analytical instruments.

	Six Months Ended March 31,
	2018		2017		Change			%
Culex, in-vivo sampling systems	$	771	$	1,271	$	(500	)		(39.3	)%
Analytical instruments		710		621		89			14.3	%
Other instruments		285		415		(130	)		(31.3	)%
	$	1,766	$	2,307	$	(541	)

Cost of Revenues

Cost of revenues for the first six months of fiscal 2018 was $8,000 or 70.7% of revenue, compared to $8,631, or 68.9% of revenue for the prior year period.

Cost of Service revenue as a percentage of Service revenue increased to 72.6% during the first six months of fiscal 2018 from 71.3% in the comparable period last year. The principal cause of this increase was the decrease in revenues, which led to lower absorption of the fixed costs in our Service segment. A significant portion of our costs of productive capacity in the Service segment are fixed. Thus, decreases in revenues led to increases in costs as a percentage of revenue.

Cost of Product revenue as a percentage of Product revenue in the first six months of fiscal 2018 increased to 60.3% from 57.9% in the comparable prior year period. This increase is mainly due to a change in the mix of products sold in the first six months of fiscal 2018, mainly due to lower sales of the Culex automated in vivo sampling systems, as well as slightly higher material costs.

Operating Expenses

Selling expenses for the six months ended March 31, 2018 increased 3.3% to $597 from $578 for the comparable fiscal 2017 period. This increase is mainly due to higher salaries and benefits from the addition of marketing personnel in late fiscal 2017 plus slightly higher travel expenses in the first six months of fiscal 2018 as compared to the prior year period, partially offset by lower commissions.

Research and development expenses for the first six months of fiscal 2018 increased 34.6% over the comparable fiscal 2017 period to $288 from $214. The increase was primarily due to higher consulting expenses and costs for operating supplies related to product development.

General and administrative expenses for the first six months of fiscal 2018 decreased 5.9% to $2,315 from $2,461 for the comparable fiscal 2017 period. The principal reason for the decrease was lower salaries and benefits expense attributable to severance expense related to the separation of our former Chief Executive Officer incurred during the first quarter of fiscal 2017, which we did not incur in the fiscal 2018 period. Also in the first six months of fiscal 2018, lower consulting services expenses were partially offset by employee search fees and higher stock option expense attributable to grants of options to our directors and certain of our employees in October 2017.

Other Income (Expense)

Other expense for the first six months of fiscal 2018 decreased to $96 from $208 for the same period of fiscal 2017. The primary reason for the change in expense was the decrease in interest expense under our new credit agreement with First Internet Bank, as described below.

Income Taxes

Our effective tax rate for the six months ended March 31, 2018 and 2017 was (224.0)% and 1.6%, respectively. The current year benefit primarily relates to an Alternative Minimum Tax (AMT) credit carryforward that will be refundable due to AMT being repealed for corporations. This will be refundable for any tax year beginning after 2017 and before 2022 in an amount equal to 50% (100% for tax years beginning in 2021) of the excess minimum tax credit for the tax year, over the amount of the credit allowable for the year against regular tax liability.

Net Income

As a result of the factors described above, net income for the six months ended March 31, 2018 amounted to $81, compared to net income of $434 in the comparable fiscal 2017 period.

Accrued Expenses

As part of a fiscal 2012 restructuring, we accrued for lease payments at the cease use date for our United Kingdom facility and have considered free rent, sublease rentals and the number of days it would take to restore the space to its original condition prior to our improvements. Based on these matters, we have a $1,000 reserve for lease related costs. Additionally, we accrued $117 for legal and professional fees and other costs to remove improvements previously made to the facility. At December 31, 2017 and September 30, 2017, respectively, we had $1,117 reserved for the liability. The reserve is classified as a current liability on the condensed consolidated balance sheets.

Liquidity and Capital Resources

Comparative Cash Flow Analysis

At March 31, 2018, we had cash and cash equivalents of $672, compared to $434 at September 30, 2017.

Net cash provided by operating activities was $842 for the six months ended March 31, 2018 compared to cash provided by operating activities of $561 for the six months ended March 31, 2017. Contributing factors to our cash provided by operations in the first six months of fiscal 2018 were noncash charges of $782 for depreciation and amortization, a net increase in customer advances of $127 and in accrued expenses of $81. These items were partially offset by, among other items, a net decrease in accounts payable of $214.

Days’ sales in accounts receivable increased to 49 days at March 31, 2018 from 48 days at September 30, 2017 due to fewer extended collections from certain customers and a slight decrease in unbilled revenues. It is not unusual to see a fluctuation in the Company's pattern of days’ sales in accounts receivable. Customers may expedite or delay payments from period-to-period for a variety of reasons including, but not limited to, the timing of capital raised to fund on-going research and development projects.

Included in operating activities for the first six months of fiscal 2017 are non-cash charges of $860 for depreciation, a net increase in customer advances of $649 and accrued expenses of $198 as well as a net decrease in prepaid expenses of $41. These items were more than offset by a net increase in accounts receivable of $997 and a decrease in accounts payable of $962.

Investing activities used $433 in the first six months of fiscal 2018 due mainly to capital expenditures as compared to $158 in the first six months of fiscal 2017. The investing activity in fiscal 2018 consisted of investments in laboratory equipment and building improvements as well as IT equipment and software.

Financing activities used $173 in the first six months of fiscal 2018, as compared to $376 used during the first six months of fiscal 2017. The main uses of cash in the first six months of fiscal 2018 were for long-term debt payments of $111 and capital lease payments of $63. The main uses of cash in the first six months of fiscal 2017 were net borrowings on our line of credit of $60 as well as long-term debt and capital lease payments of $327 and $64, respectively.

Capital Resources

Credit Facility

On June 23, 2017, we entered into a Credit Agreement (the “Credit Agreement”) with First Internet Bank of Indiana (“FIB”). The Credit Agreement includes both a term loan and a revolving line of credit and is secured by mortgages on our facilities and personal property in West Lafayette and Evansville, Indiana. We used the proceeds from the term loan to satisfy our indebtedness with Huntington Bank and terminated the related interest rate swap, as more fully described in Note 7 to the condensed consolidated financial statements.

The term loan for $4,500 bears interest at a fixed rate of 3.99%, with monthly principal and interest payments of approximately $33. The term loan matures in June 2022. The balance on the term loan at March 31, 2018 was $4,335. The revolving line of credit for up to $2,000 matures in June 2019 and bears interest at the Prime Rate (generally defined as the highest rate identified as the “Prime Rate” in The Wall Street Journal “Money Rates” column on the date the interest rate is to be determined, or if that date is not a publication date, on the publication date immediately preceding) less Twenty-five (25) Basis Points (0.25%). The balance on the revolving line of credit at March 31, 2018 was $0. We must pay accrued and unpaid interest on the outstanding balance under the credit line on a monthly basis.

The Credit Agreement contains various restrictive covenants, including restrictions on the Company's ability to dispose of assets, make acquisitions or investments, incur debt or liens, make distributions to shareholders or repurchase outstanding stock, enter into related party transactions and make capital expenditures, other than upon satisfaction of the conditions set forth in the Credit Agreement. The Credit Agreement also requires us to maintain (i) a minimum debt service coverage ratio of not less than 1.25 to 1.0 for the quarters thereafter and (ii) a debt to equity ratio of not greater than 2.50 to 1.00 until maturity. Upon an event of default, which includes certain customary events such as, among other things, a failure to make required payments when due, a failure to comply with covenants, certain bankruptcy and insolvency events, and defaults under other material indebtedness, FIB may cease advancing funds, increase the interest rate on outstanding balances, accelerate amounts outstanding, terminate the agreement and foreclose on all collateral. The Company was in compliance with these covenants as of March 31, 2018.

We incurred $69 of costs in June 2017 related to the Credit Agreement that was partially amortized in the third and fourth fiscal quarters of 2017 and the first and second fiscal quarters of 2018 with the remainder to be amortized through June 2022.

The Company’s sources of liquidity for the remainder of fiscal 2018 are expected to consist primarily of cash generated from operations, cash on-hand and, if needed, borrowings under our revolving credit facility or as otherwise may be available. Management believes that the resources described above will be sufficient to fund operations, planned capital expenditures and working capital requirements over the next twelve months.

ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

A smaller reporting company is not required to provide the information required by this Item 3.

ITEM 4 - CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information, which is required to be disclosed timely, is accumulated and communicated to management in a timely fashion. In designing and evaluating such controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Our management is necessarily required to use judgment in evaluating controls and procedures.

Management performs periodic evaluations to determine if our disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to management, including our acting principal executive officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure and are effective to provide reasonable assurance that such information is recorded, processed, summarized and reported within the time periods specified by the SEC's rules and forms. An evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report was performed under the supervision and with the participation of management, which resulted in a determination by our acting principal executive officer and Chief Financial Officer that our disclosure controls and procedures were effective as of March 31, 2018.

Changes in Internal Controls

There were no changes in the Company's internal control over financial reporting during the second quarter of fiscal 2018 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

PART II

ITEM 1A - RISK FACTORS

Before investing in our securities you should carefully consider the risks described in our Annual Report on Form 10-K for the fiscal year ended September 30, 2017, including those disclosed under the heading “Risk Factors” appearing in Item 1A of Part I of the Form 10-K, as well as the information contained in this Quarterly Report. Realization of any of these risks could have a material adverse effect on our business, financial condition, cash flows and results of operations.

ITEM 6 - EXHIBITS

(a)

Exhibits:

See the Exhibit Index to this Form 10-Q, which is incorporated herein by reference.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized:

	BIOANALYTICAL SYSTEMS, INC.
	(Registrant)

Date: May 15, 2018	By:	/s/ Philip A. Downing
		Philip A. Downing
		Senior Vice President, Preclinical Services (Acting Principal Executive Officer)

Date: May 15, 2018	By:	/s/ Jill C. Blumhoff
		Jill C. Blumhoff
		Chief Financial Officer and Vice President of Finance
		(Principal Financial Officer and Accounting Officer)

EXHIBIT INDEX

Number		Description of Exhibits

(31)	31.1	Certification of Acting Principal Executive Officer (filed herewith).

	31.2	Certification of Chief Financial Officer (filed herewith).

(32)	32.1	Written Statement of Acting Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350) (filed herewith).^.

	32.2	Written Statement of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350) (filed herewith).^.

	101	XBRL data file (filed herewith)

EX-31.1 2 tv493923_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATIONS

I, Philip A. Downing, Acting Principal Executive Officer, certify that:

I have reviewed this report on Form 10-Q of Bioanalytical Systems, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions);

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: May 15, 2018		/s/ Philip A. Downing
		Philip A. Downing Acting Principal Executive Officer

EX-31.2 3 tv493923_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

CERTIFICATIONS

I, Jill C. Blumhoff, Vice President of Finance and Chief Financial Officer, certify that:

I have reviewed this report on Form 10-Q of Bioanalytical Systems, Inc.;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: May 15, 2018		/s/ Jill C. Blumhoff
		Jill C. Blumhoff
		Vice President of Finance and Chief Financial Officer

EX-32.1 4 tv493923_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

Certifications of Acting Principal Executive Officer

Pursuant to Section 906

Of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

The undersigned, the Acting Principal Executive Officer of Bioanalytical Systems Inc. (the “Company”), hereby certifies that, to the best of his knowledge:

(a)

the Form 10-Q Quarterly Report of the Company for the three and six months ended March 31, 2018 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


	By:	/s/ Philip A. Downing
		Philip A. Downing Acting Principal Executive Officer
		Date: May 15, 2018

EX-32.2 5 tv493923_ex32-2.htm EXHIBIT 32.2

Exhibit 32.2

Certifications of Chief Financial Officer

Pursuant to Section 906

Of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

The undersigned, the Vice President of Finance and Chief Financial Officer of Bioanalytical Systems Inc. (the “Company”), hereby certifies that, to the best of her knowledge:

(a)

(b)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


	By:	/s/ Jill C. Blumhoff
		Jill C. Blumhoff
		Vice President of Finance and Chief Financial Officer
		Date: May 15, 2018

EX-101.INS 6 basi-20180331.xml XBRL INSTANCE DOCUMENT 0000720154 2017-01-01 2017-03-31 0000720154 2018-01-01 2018-03-31 0000720154 2018-03-31 0000720154 2018-05-10 0000720154 2017-09-30 0000720154 2016-10-01 2017-03-31 0000720154 2016-10-01 2017-09-30 0000720154 2017-10-01 2018-03-31 0000720154 2016-09-30 0000720154 2017-03-31 0000720154 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-03-31 0000720154 us-gaap:EmployeeStockOptionMember 2017-10-01 2018-03-31 0000720154 us-gaap:EmployeeStockOptionMember 2017-09-30 0000720154 us-gaap:EmployeeStockOptionMember 2018-03-31 0000720154 basi:ProductsSegmentMember 2016-10-01 2017-03-31 0000720154 basi:ProductsSegmentMember 2017-10-01 2018-03-31 0000720154 basi:ServicesSegmentMember 2016-10-01 2017-03-31 0000720154 basi:ServicesSegmentMember 2017-10-01 2018-03-31 0000720154 basi:ProductsSegmentMember 2017-01-01 2017-03-31 0000720154 basi:ProductsSegmentMember 2018-01-01 2018-03-31 0000720154 basi:ServicesSegmentMember 2017-01-01 2017-03-31 0000720154 basi:ServicesSegmentMember 2018-01-01 2018-03-31 0000720154 us-gaap:ScenarioPlanMember 2017-10-01 2018-09-30 0000720154 basi:FirstInternetBankOfIndianaMember 2018-03-31 0000720154 basi:FirstInternetBankOfIndianaMember 2017-10-01 2018-03-31 0000720154 basi:FirstInternetBankOfIndianaMember 2017-09-30 0000720154 basi:FirstInternetBankOfIndianaMember 2018-01-01 2018-03-31 0000720154 basi:FirstInternetBankOfIndianaMember 2016-10-01 2017-06-30 0000720154 basi:HuntingtonBankMember 2016-10-01 2017-06-30 0000720154 us-gaap:InterestRateSwapMember 2018-03-31 0000720154 basi:HuntingtonBankMember 2018-03-31 0000720154 us-gaap:ContractTerminationMember 2018-03-31 0000720154 us-gaap:SeriesAPreferredStockMember 2018-03-31 0000720154 us-gaap:SeriesAPreferredStockMember 2017-09-30 0000720154 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-03-31 0000720154 us-gaap:EmployeeStockOptionMember 2016-10-01 2017-03-31 0000720154 basi:FirstInternetBankOfIndianaMember 2017-01-01 2017-03-31 0000720154 basi:FirstInternetBankOfIndianaMember 2016-10-01 2017-03-31 0000720154 basi:TwoThousandEighteenEquityIncentivePlanMember 2018-03-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 10-Q false 2018-03-31 2018 Q2 BIOANALYTICAL SYSTEMS INC 0000720154 --09-30 Smaller Reporting Company BASI 8245320

672000

434000

2726000

2530000

410000 615000

1000000

913000

742000

814000

5550000

5306000

14625000

14965000

38000

18000

21000

20400000

20417000

1838000

2052000

1283000

1202000

3107000

2980000

26000

20000

7731000

7723000

11782000

11950000

2023000

21516000

21446000

-15956000

-16037000

8618000

8467000

20400000

20417000

102000

87000

1117000

132000

128000

228000

224000

2000

69000

4049000

4158000

1035000

67000

9555000

10226000

1766000

2307000

11321000

12533000

6935000

7296000

1065000

1335000

8000000

8631000

3321000

3902000

597000

578000

288000

214000

2315000

2461000

3200000

3253000

121000

649000

100000

210000

25000

441000

-56000

7000

81000

434000

81000

463000

0.01

0.05

0.01

0.05

8245000

8128000

8793000

8707000

-29000

4000

2000

5030000

4962000

914000

1397000

5944000

6359000

3662000

3546000

542000

770000

4204000

4316000

1740000

2043000

303000

242000

149000

110000

1178000

1136000

1630000

1488000

110000

555000

48000

134000

66000

422000

11000

5000

55000

417000

55000

425000

0.01

0.05

0.01

0.05

8245000

8148000

8789000

8710000

-8000

4000

1000

782000

860000

69000

7000

1000

6000

3000

997000

87000

-334000

-61000

3000

-72000

-41000

-214000

-962000

81000

198000

127000

649000

842000

561000

433000

158000

-431000

-152000

111000

327000

63000

64000

-173000

-376000

386000

419000

45000

6000

238000

33000

2000

94000

139000

5085000

6823000

35000

69000

140000

2000

198000

13000

323000

1.91

1.4

1.94

4.46

1.83

1.45 1.15

1.52

1.45

P8Y

250000

P1Y4M24D

55000

417000

55000

417000

518000

554000

26000

8000

81000

434000

81000

434000

518000

573000

30000

6000

797000

761000

185000

135000

244000

228000

211000

226000

-90000

-305000

739000

426000

2307000

1766000

10226000

9555000

110000

-134000

445000

244000

1397000

914000

4962000

5030000

0.35

0.21

27000

4500000

0.0399

33000

4335000

2000000

4000

7000

69000

27000 100000

56000

0.6

0.050

1000000

117000

1000000

1035

1000

19000000

8245320

8243896

8245320

8243896

2019000

2404000

-4000

5085000

6883000

1000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"><strong> 2.</strong></font></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>STOCK-BASED COMPENSATION</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The Company’s 2008 Stock Option Plan (“the Plan”) is used to promote our long-term interests by providing a means of attracting and retaining officers, directors and key employees and aligning their interests with those of our shareholders. The Plan is described more fully in Note 9 in the Notes to the Consolidated Financial Statements in our Form 10-K for the fiscal year ended September 30, 2017. All options granted under the Plan had an exercise price equal to the market value of the underlying common shares on the date of grant. We expense the estimated fair value of stock options over the vesting periods of the grants. We recognize expense for awards subject to graded vesting using the straight-line attribution method, reduced for estimated forfeitures. Forfeitures are revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates and an adjustment is recognized at that time. Stock based compensation expense for the three and six months ended March 31, 2018 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">35</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">69</font>, respectively. Stock based compensation expense for the three and six months ended March 31, 2017 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">(3)</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7</font>, respectively. The negative expense in the three month period ending March 31, 2017 was due to the forfeiture of options related to our former Chief Executive Officer.</div>  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">In March 2018, our shareholders approved the amendment and restatement of the Plan in the form of the Amended and Restated 2018 Equity Incentive Plan (the “Equity Plan”) and future equity awards will be granted from the Equity Plan. Future common shares will be granted from the 2018 Equity Incentive Plan. The purpose of the Equity Plan is to promote our long-term interests by providing a means of attracting and retaining officers, directors and key employees. The maximum number of common shares that may be granted under the Equity Plan is 700 shares.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>A summary of our stock option activity for the six months ended March 31, 2018 is as follows (in thousands except for share prices):</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0px:auto; WIDTH: 60%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Options<br/> (shares)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Weighted-<br/> Average<br/> Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Weighted-<br/> Average<br/> Grant Date<br/> Fair Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%"> <div>Outstanding - October 1, 2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>140</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.91</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.45</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.40</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.15</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>198</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.94</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.52</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(13)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4.46</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%"> <div>Outstanding - March 31, 2018</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>323</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.83</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.45</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The weighted-average assumptions used to compute the fair value of the options granted in the six months ended March 31, 2018 were as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0px:auto; WIDTH: 50%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.31</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Dividend yield</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Volatility of the expected market price of the Company's common shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>83.70</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Expected life of the options (years)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8.0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">As of March 31, 2018, our total unrecognized compensation cost related to non-vested stock options was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250</font> and is expected to be recognized over a weighted-average service period of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.4</font> years.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

-3000

7000

0.0231

0.8370

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"> <strong>3.</strong></font></td> <td style="TEXT-ALIGN: justify"><strong>INCOME (LOSS) PER SHARE</strong></td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">We compute basic income per share using the weighted average number of common shares outstanding. The Company has two categories of dilutive potential common shares: Series A preferred shares issued in May 2011 in connection with our registered direct offering and shares issuable upon exercise of options. We compute diluted earnings per share using the if-converted method for preferred stock and the treasury stock method for stock options, respectively.</div> </div>  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The following table reconciles our computation of basic income per share to diluted income per share:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0px:auto; WIDTH: 92%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three Months Ended<br/> March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Six Months Ended<br/> March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2018</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2018</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Basic net income per share:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Net income applicable to common shareholders</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>55</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>417</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>81</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>434</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Weighted average common shares outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,245</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,148</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,245</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,128</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Basic net income per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.05</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.05</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Diluted net income per share:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Diluted net income applicable to common shareholders</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>55</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>417</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>81</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>434</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Weighted average common shares outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,245</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,148</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,245</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,128</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Plus: Incremental shares from assumed conversions:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Series A preferred shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>518</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>554</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>518</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>573</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Dilutive stock options/shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>26</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>30</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Diluted weighted average common shares outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,789</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,710</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,793</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,707</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Diluted net income per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.05</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.05</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The following table reconciles our computation of basic income per share to diluted income per share:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0px:auto; WIDTH: 92%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three Months Ended<br/> March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Six Months Ended<br/> March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2018</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2018</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Basic net income per share:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Net income applicable to common shareholders</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>55</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>417</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>81</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>434</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Weighted average common shares outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,245</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,148</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,245</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,128</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Basic net income per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.05</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.05</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Diluted net income per share:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Diluted net income applicable to common shareholders</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>55</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>417</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>81</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>434</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Weighted average common shares outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,245</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,148</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,245</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,128</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Plus: Incremental shares from assumed conversions:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Series A preferred shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>518</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>554</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>518</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>573</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Dilutive stock options/shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>26</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>30</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Diluted weighted average common shares outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,789</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,710</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,793</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,707</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Diluted net income per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.05</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.05</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Inventories consisted of the following:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 65%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>March 31,<br/> 2018</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>September 30,<br/> 2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Raw materials</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>797</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>761</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Work in progress</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>185</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>135</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Finished goods</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>244</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>228</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,226</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,124</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Obsolescence reserve</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(226)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(211)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>913</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

1226000

1124000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"> <strong>5.</strong></font></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>SEGMENT INFORMATION</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to the Consolidated Financial Statements in our annual report on Form 10-K for the fiscal year ended September 30, 2017.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><strong> </strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 88%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three Months Ended<br/> March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Six Months Ended<br/> March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2018</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2018</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Revenue:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 52px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Service</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,030</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,962</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,555</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,226</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 52px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Product</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>914</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,397</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,766</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,307</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,944</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>6,359</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>11,321</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>12,533</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Operating Income</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 52px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Service</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>244</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>445</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>739</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 52px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Product</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(134)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>110</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(305)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(90)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>110</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>555</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>121</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>649</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Interest expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(48)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(134)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(100)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(210)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Other income</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Income before income taxes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>66</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>422</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>25</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>441</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 88%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three Months Ended<br/> March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Six Months Ended<br/> March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2018</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2018</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Revenue:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 52px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Service</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,030</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,962</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,555</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,226</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 52px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Product</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>914</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,397</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,766</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,307</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,944</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>6,359</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>11,321</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>12,533</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Operating Income</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 52px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Service</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>244</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>445</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>739</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 52px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Product</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(134)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>110</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(305)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(90)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>110</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>555</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>121</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>649</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Interest expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(48)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(134)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(100)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(210)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Other income</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Income before income taxes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>66</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>422</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>25</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>441</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

5944000

6359000

11321000

12533000

0.245

-2.240

1600000

16000

82000

103000

less Twenty-five (25) Basis Points (0.25%).

700000

57000

64000

EX-101.SCH 7 basi-20180331.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME link:presentationLink link:definitionLink link:calculationLink 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 106 - Disclosure - DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION link:presentationLink link:definitionLink link:calculationLink 107 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - INCOME (LOSS) PER SHARE link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - INVENTORIES link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - SEGMENT INFORMATION link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - INCOME TAXES link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - DEBT link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - ACCRUED EXPENSES link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - INCOME (LOSS) PER SHARE (Tables) link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - INVENTORIES (Tables) link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - STOCK-BASED COMPENSATION (Details) link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - STOCK-BASED COMPENSATION (Details 1) link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - STOCK-BASED COMPENSATION (Details Textual) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - INCOME (LOSS) PER SHARE (Details) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - INVENTORIES (Details) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - SEGMENT INFORMATION (Details) link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - INCOME TAXES (Details Textual) link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - DEBT (Details Textual) link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - ACCRUED EXPENSES (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 basi-20180331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 basi-20180331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 basi-20180331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information [Abstract] Document Information [Table] Class of Stock [Axis] Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Trading Symbol Entity Common Stock, Shares Outstanding Statement of Financial Position [Abstract] Statement [Table] Class of Stock [Domain] Statement [Line Items] Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Accounts Receivable, Net, Current [Abstract] Accounts receivable Accounts Receivable, Net, Current Trade, net of allowance of $2,019 at March 31, 2018 and $2,404 at September 30, 2017 Unbilled Revenue And Other Current Unbilled revenues and other Unbilled Revenue and Other, Current Inventory, Net Inventories, net Inventories Prepaid Expense, Current Prepaid expenses Property, Plant and Equipment, Net Property and equipment, net Net property and equipment Lease Incentive Receivable, Noncurrent Lease rent receivable Deferred Income Tax Assets, Net Deferred tax asset Goodwill Goodwill Goodwill, net: Balance Balance Liabilities and Equity [Abstract] Liabilities and shareholders’ equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Restructuring Reserve, Current Restructuring liability Accrued Liabilities, Current Accrued expenses Customer Advances, Current Customer advances Accrued Income Taxes, Current Income taxes payable Capital Lease Obligations, Current Current portion of capital lease obligation Capital Lease Obligations, Noncurrent Capital lease obligation, less current portion Long-term Debt, Excluding Current Maturities Long-term debt, less current portion, net of debt issuance costs Long term total Preferred Stock, Value, Issued Preferred shares, authorized 1,000,000 shares, no par value: 1,035 Series A shares at $1,000 stated value issued and outstanding at March 31, 2018 and at September 30, 2017 Common Stock, Value, Issued Common shares, no par value: Authorized 19,000,000 shares; 8,245,320 issued and outstanding at March 31, 2018 and 8,243,896 at September 30, 2017 Additional Paid in Capital, Total Additional paid-in capital Retained Earnings (Accumulated Deficit), Total Accumulated deficit Stockholders' Equity Attributable to Parent, Total Total shareholders’ equity Balance Balance Liabilities Total liabilities Allowance for Doubtful Accounts Receivable, Current Preferred Stock, Shares Authorized Preferred Stock, No Par Value Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Preferred Stock, Par or Stated Value Per Share Common Stock, No Par Value Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Series A Preferred Stock [Member] Income Statement [Abstract] Sales Revenue, Services, Net, Total Service revenue Sales Revenue, Goods, Net, Total Product revenue Revenue, Net, Total Total revenue Cost of Services, Total Cost of service revenue Cost of Goods Sold, Total Cost of product revenue Cost of Goods and Services Sold, Total Total cost of revenue Gross Profit, Total Gross profit Operating Expenses [Abstract] Operating expenses: Selling Expense Selling Research and Development Expense, Total Research and development General and Administrative Expense, Total General and administrative Operating Expenses, Total Total operating expenses Operating Income (Loss), Total Operating income Operating income (loss): Interest Expense, Total Interest expense Interest expense Other Nonoperating Income (Expense), Total Other income Other income Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest, Total Net income before income taxes Income before income taxes Income Tax Expense (Benefit) Income taxes (benefit) expense Income tax expense Net Income (Loss) Attributable to Parent, Total Net income Net income (loss) Net income Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Other comprehensive income: Other comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total Comprehensive income Earnings Per Share, Basic, Total Basic net income per share Basic net income per share Earnings Per Share, Diluted, Total Diluted net income per share Diluted net income per share Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted common shares outstanding: Weighted Average Number of Shares Outstanding, Basic Basic Weighted average common shares outstanding Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted Diluted Diluted weighted average common shares outstanding Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] Operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided by operating activities: Depreciation, Depletion and Amortization, Nonproduction, Total Depreciation and amortization Depreciation and amortization: Share-based Compensation, Total Stock based compensation expense Employee stock compensation expense Provision for Doubtful Accounts Provision for doubtful accounts Charged to expense Gain (Loss) on Disposition of Property Plant Equipment, Total Gain on disposal of property and equipment Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Inventories, Total Inventories Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable Income tax accruals Increase (Decrease) in Prepaid Expense and Other Assets, Total Prepaid expenses and other assets Increase (Decrease) in Accounts Payable, Total Accounts payable Increase (Decrease) in Accrued Liabilities, Total Accrued expenses Increase (Decrease) in Customer Advances Customer advances Net Cash Provided by (Used in) Operating Activities Net cash provided by operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Investing activities: Payments for (Proceeds from) Productive Assets, Total Capital expenditures Proceeds from Sale of Machinery and Equipment Proceeds from sale of equipment Net Cash Provided by (Used in) Investing Activities Net cash used by investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Financing activities: Repayments of Long-term Debt, Total Payments of long-term debt Payments of Debt Issuance Costs Payments of debt issuance costs Repayments of Lines of Credit Payments on revolving line of credit Proceeds from Lines of Credit Borrowings on revolving line of credit Proceeds from Stock Options Exercised Proceeds from exercise of stock options Repayments of Long-term Capital Lease Obligations Payments on capital lease obligations Net Cash Provided by (Used in) Financing Activities Net cash used by financing activities Cash and Cash Equivalents, Period Increase (Decrease), Total Net increase in cash and cash equivalents Supplemental Cash Flow Information [Abstract] Supplemental disclosure of cash flow information: Interest Paid, Net Cash paid for interest Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of non-cash financing activities: Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION Payables and Accruals [Abstract] Accounts Payable and Accrued Liabilities Disclosure [Text Block] ACCRUED EXPENSES Restructuring and Related Activities [Abstract] Schedule of Restructuring and Related Costs [Table] Segments [Axis] Restructuring Reserve Restructuring reserves Balance Balance Restructuring Type [Axis] Segments [Domain] Scenario [Axis] Type of Restructuring [Domain] Contract Termination [Member] Lease Related Costs Lease Related Costs [Member] Balance Sheet Location [Axis] Scenario, Unspecified [Domain] Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Disclosure [Text Block] SEGMENT INFORMATION Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Operating Segments Revenues, Total Revenue Segment Reporting Information [Line Items] Services Segment [Member] Service Segment [Member] Products Segment [Member] Product Segment [Member] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] STOCK-BASED COMPENSATION Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Share-based Compensation, Stock Options, Activity Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Equity Award [Domain] Employee Stock Option [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Volatility of the expected market price of the Company's common shares Earnings Per Share [Abstract] Earnings Per Share [Text Block] INCOME (LOSS) PER SHARE Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Earnings Per Share, Basic and Diluted Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table] Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance Options (shares) Outstanding Options (shares) Outstanding Earnings Per Share, Basic [Abstract] Basic net income per share: Net Income (Loss) Available to Common Stockholders, Basic, Total Net income applicable to common shareholders Net (loss) income applicable to common shareholders Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Stock option exercise (in shares) Options (shares) Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Options (shares) Granted Earnings Per Share, Diluted [Abstract] Diluted net income per share: Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Options (shares) Forfeited Net Income (Loss) Available to Common Stockholders, Diluted, Total Diluted net income applicable to common shareholders Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract] Plus: Incremental shares from assumed conversions: Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock Series A preferred shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance Weighted-Average Exercise Price Outstanding Weighted-Average Exercise Price Outstanding Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Dilutive stock options/shares Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted-Average Exercise Price Exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted-Average Exercise Price Granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted-Average Exercise Price Forfeited Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Weighted-Average Grant Date Fair Value Outstanding Weighted-Average Grant Date Fair Value Outstanding The weighted average grant-date fair value of options outstanding as calculated by applying the disclosed option pricing methodology. Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Grant Date Fair Value Weighted-Average Grant Date Fair Value Exercised The weighted average grant-date fair value of options exercised during the reporting period as calculated by applying the disclosed option pricing methodology. Inventory Disclosure [Abstract] Inventory Disclosure [Text Block] INVENTORIES Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-Average Grant Date Fair Value Granted Schedule of Inventory, Current [Table Text Block] Schedule of Inventory, Current Inventory, Current [Table] Inventory [Line Items] Inventory, Raw Materials, Gross Raw materials Inventory, Work in Process, Gross Work in progress Inventory, Finished Goods, Gross Finished goods Inventory, Gross, Total Gross inventories Inventory Valuation Reserves Obsolescence reserve Equity Components [Axis] Equity Component [Domain] Plan Name [Axis] Plan Name [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Allocated Share-based Compensation Expense EX-101.PRE 11 basi-20180331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Mar. 31, 2018	May 10, 2018
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q2
Entity Registrant Name	BIOANALYTICAL SYSTEMS INC
Entity Central Index Key	0000720154
Current Fiscal Year End Date	--09-30
Entity Filer Category	Smaller Reporting Company
Trading Symbol	BASI
Entity Common Stock, Shares Outstanding		8,245,320

XML 13 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2018	Sep. 30, 2017
Current assets:
Cash and cash equivalents	$ 672	$ 434
Accounts receivable
Trade, net of allowance of $2,019 at March 31, 2018 and $2,404 at September 30, 2017	2,726	2,530
Unbilled revenues and other	410	615
Inventories, net	1,000	913
Prepaid expenses	742	814
Total current assets	5,550	5,306
Property and equipment, net	14,625	14,965
Lease rent receivable	102	87
Deferred tax asset	67	0
Goodwill	38	38
Other assets	18	21
Total assets	20,400	20,417
Current liabilities:
Accounts payable	1,838	2,052
Restructuring liability	1,117	1,117
Accrued expenses	1,283	1,202
Customer advances	3,107	2,980
Income taxes payable	26	20
Current portion of capital lease obligation	132	128
Current portion of long-term debt	228	224
Total current liabilities	7,731	7,723
Capital lease obligation, less current portion	2	69
Long-term debt, less current portion, net of debt issuance costs	4,049	4,158
Total liabilities	11,782	11,950
Shareholders’ equity:
Preferred shares, authorized 1,000,000 shares, no par value: 1,035 Series A shares at $1,000 stated value issued and outstanding at March 31, 2018 and at September 30, 2017	1,035	1,035
Common shares, no par value: Authorized 19,000,000 shares; 8,245,320 issued and outstanding at March 31, 2018 and 8,243,896 at September 30, 2017	2,023	2,023
Additional paid-in capital	21,516	21,446
Accumulated deficit	(15,956)	(16,037)
Total shareholders’ equity	8,618	8,467
Total liabilities and shareholders’ equity	$ 20,400	$ 20,417

XML 14 R3.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2018	Sep. 30, 2017
Allowance for Doubtful Accounts Receivable, Current	$ 2,019	$ 2,404
Common Stock, No Par Value	$ 0	$ 0
Common Stock, Shares Authorized	19,000,000	19,000,000
Common Stock, Shares, Issued	8,245,320	8,243,896
Common Stock, Shares, Outstanding	8,245,320	8,243,896
Series A Preferred Stock [Member]
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock, No Par Value	$ 0	$ 0
Preferred Stock, Shares Issued	1,035	1,035
Preferred Stock, Shares Outstanding	1,035	1,035
Preferred Stock, Par or Stated Value Per Share	$ 1,000	$ 1,000

XML 15 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Service revenue	$ 5,030	$ 4,962	$ 9,555	$ 10,226
Product revenue	914	1,397	1,766	2,307
Total revenue	5,944	6,359	11,321	12,533
Cost of service revenue	3,662	3,546	6,935	7,296
Cost of product revenue	542	770	1,065	1,335
Total cost of revenue	4,204	4,316	8,000	8,631
Gross profit	1,740	2,043	3,321	3,902
Operating expenses:
Selling	303	242	597	578
Research and development	149	110	288	214
General and administrative	1,178	1,136	2,315	2,461
Total operating expenses	1,630	1,488	3,200	3,253
Operating income	110	555	121	649
Interest expense	(48)	(134)	(100)	(210)
Other income	4	1	4	2
Net income before income taxes	66	422	25	441
Income taxes (benefit) expense	11	5	(56)	7
Net income	55	417	81	434
Other comprehensive income:	0	8	0	29
Comprehensive income	$ 55	$ 425	$ 81	$ 463
Basic net income per share	$ 0.01	$ 0.05	$ 0.01	$ 0.05
Diluted net income per share	$ 0.01	$ 0.05	$ 0.01	$ 0.05
Weighted common shares outstanding:
Basic	8,245	8,148	8,245	8,128
Diluted	8,789	8,710	8,793	8,707

XML 16 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Operating activities:
Net income	$ 81	$ 434
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	782	860
Employee stock compensation expense	69	7
Provision for doubtful accounts	(4)	0
Gain on disposal of property and equipment	(1)	(6)
Changes in operating assets and liabilities:
Accounts receivable	(3)	(997)
Inventories	(87)	334
Income tax accruals	(61)	3
Prepaid expenses and other assets	72	41
Accounts payable	(214)	(962)
Accrued expenses	81	198
Customer advances	127	649
Net cash provided by operating activities	842	561
Investing activities:
Capital expenditures	(433)	(158)
Proceeds from sale of equipment	2	6
Net cash used by investing activities	(431)	(152)
Financing activities:
Payments of long-term debt	(111)	(327)
Payments of debt issuance costs	0	(45)
Payments on revolving line of credit	(5,085)	(6,823)
Borrowings on revolving line of credit	5,085	6,883
Proceeds from exercise of stock options	1	0
Payments on capital lease obligations	(63)	(64)
Net cash used by financing activities	(173)	(376)
Net increase in cash and cash equivalents	238	33
Cash and cash equivalents at beginning of period	434	386
Cash and cash equivalents at end of period	672	419
Supplemental disclosure of non-cash financing activities:
Cash paid for interest	$ 94	$ 139

XML 17 R6.htm IDEA: XBRL DOCUMENT

DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION

6 Months Ended

Mar. 31, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION

DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION

XML 18 R7.htm IDEA: XBRL DOCUMENT

STOCK-BASED COMPENSATION

6 Months Ended

Mar. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK-BASED COMPENSATION

2.	STOCK-BASED COMPENSATION

A summary of our stock option activity for the six months ended March 31, 2018 is as follows (in thousands except for share prices):

	Options (shares)		Weighted- Average Exercise Price		Weighted- Average Grant Date Fair Value

Outstanding - October 1, 2017		140	$	1.91	$	1.45
Exercised		(2)	$	1.40	$	1.15
Granted		198	$	1.94	$	1.52
Forfeited		(13)	$	4.46
Outstanding - March 31, 2018		323	$	1.83	$	1.45

The weighted-average assumptions used to compute the fair value of the options granted in the six months ended March 31, 2018 were as follows:

Risk-free interest rate	2.31	%
Dividend yield	0.00	%
Volatility of the expected market price of the Company's common shares	83.70	%
Expected life of the options (years)	8.0

As of March 31, 2018, our total unrecognized compensation cost related to non-vested stock options was $250 and is expected to be recognized over a weighted-average service period of 1.4 years.

XML 19 R8.htm IDEA: XBRL DOCUMENT

INCOME (LOSS) PER SHARE

6 Months Ended

Mar. 31, 2018

Earnings Per Share [Abstract]

INCOME (LOSS) PER SHARE

3.	INCOME (LOSS) PER SHARE

The following table reconciles our computation of basic income per share to diluted income per share:

	Three Months Ended March 31,				Six Months Ended March 31,
	2018		2017		2018		2017
Basic net income per share:
Net income applicable to common shareholders	$	55	$	417	$	81	$	434
Weighted average common shares outstanding		8,245		8,148		8,245		8,128
Basic net income per share	$	0.01	$	0.05	$	0.01	$	0.05
Diluted net income per share:
Diluted net income applicable to common shareholders	$	55	$	417	$	81	$	434

Weighted average common shares outstanding		8,245		8,148		8,245		8,128
Plus: Incremental shares from assumed conversions:
Series A preferred shares		518		554		518		573
Dilutive stock options/shares		26		8		30		6
Diluted weighted average common shares outstanding		8,789		8,710		8,793		8,707
Diluted net income per share	$	0.01	$	0.05	$	0.01	$	0.05

XML 20 R9.htm IDEA: XBRL DOCUMENT

INVENTORIES

6 Months Ended

Mar. 31, 2018

Inventory Disclosure [Abstract]

INVENTORIES

4.	INVENTORIES

Inventories consisted of the following:

	March 31, 2018		September 30, 2017

Raw materials	$	797	$	761
Work in progress		185		135
Finished goods		244		228
	$	1,226	$	1,124
Obsolescence reserve		(226)		(211)
	$	1,000	$	913

XML 21 R10.htm IDEA: XBRL DOCUMENT

SEGMENT INFORMATION

6 Months Ended

Mar. 31, 2018

Segment Reporting [Abstract]

SEGMENT INFORMATION

5.	SEGMENT INFORMATION

	Three Months Ended March 31,				Six Months Ended March 31,
	2018		2017		2018		2017

Revenue:
Service	$	5,030	$	4,962	$	9,555	$	10,226
Product		914		1,397		1,766		2,307
	$	5,944	$	6,359	$	11,321	$	12,533

Operating Income
Service	$	244	$	445	$	426	$	739
Product		(134)		110		(305)		(90)
	$	110	$	555	$	121	$	649

Interest expense		(48)		(134)		(100)		(210)
Other income		4		1		4		2
Income before income taxes	$	66	$	422	$	25	$	441

XML 22 R11.htm IDEA: XBRL DOCUMENT

INCOME TAXES

6 Months Ended

Mar. 31, 2018

Income Tax Disclosure [Abstract]

INCOME TAXES

6.	INCOME TAXES

At March 31, 2018 and September 30, 2017, we had a $27 and $16 liability, respectively, for uncertain income tax positions.

We file income tax returns in the U.S. and several U.S. States. We remain subject to examination by taxing authorities in the jurisdictions in which we have filed returns for years after 2012.

XML 23 R12.htm IDEA: XBRL DOCUMENT

DEBT

6 Months Ended

Mar. 31, 2018

Debt Disclosure [Abstract]

DEBT

DEBT

Credit Facility

Former Credit Facility

We incurred a total of $56 of costs related to certain of our forbearance arrangements that was amortized in the first, second and third quarters of fiscal 2017.

Former Interest Rate Swap

XML 24 R13.htm IDEA: XBRL DOCUMENT

ACCRUED EXPENSES

6 Months Ended

Mar. 31, 2018

Payables and Accruals [Abstract]

ACCRUED EXPENSES

8.	ACCRUED EXPENSES

XML 25 R14.htm IDEA: XBRL DOCUMENT

NEW ACCOUNTING PRONOUNCEMENTS

6 Months Ended

Mar. 31, 2018

Accounting Changes and Error Corrections [Abstract]

NEW ACCOUNTING PRONOUNCEMENTS

9.	NEW ACCOUNTING PRONOUNCEMENTS

XML 26 R15.htm IDEA: XBRL DOCUMENT

STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Mar. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity

A summary of our stock option activity for the six months ended March 31, 2018 is as follows (in thousands except for share prices):

	Options (shares)		Weighted- Average Exercise Price		Weighted- Average Grant Date Fair Value

Outstanding - October 1, 2017		140	$	1.91	$	1.45
Exercised		(2)	$	1.40	$	1.15
Granted		198	$	1.94	$	1.52
Forfeited		(13)	$	4.46
Outstanding - March 31, 2018		323	$	1.83	$	1.45

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The weighted-average assumptions used to compute the fair value of the options granted in the six months ended March 31, 2018 were as follows:

Risk-free interest rate	2.31	%
Dividend yield	0.00	%
Volatility of the expected market price of the Company's common shares	83.70	%
Expected life of the options (years)	8.0

XML 27 R16.htm IDEA: XBRL DOCUMENT

INCOME (LOSS) PER SHARE (Tables)

6 Months Ended

Mar. 31, 2018

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table reconciles our computation of basic income per share to diluted income per share:

	Three Months Ended March 31,				Six Months Ended March 31,
	2018		2017		2018		2017
Basic net income per share:
Net income applicable to common shareholders	$	55	$	417	$	81	$	434
Weighted average common shares outstanding		8,245		8,148		8,245		8,128
Basic net income per share	$	0.01	$	0.05	$	0.01	$	0.05
Diluted net income per share:
Diluted net income applicable to common shareholders	$	55	$	417	$	81	$	434

Weighted average common shares outstanding		8,245		8,148		8,245		8,128
Plus: Incremental shares from assumed conversions:
Series A preferred shares		518		554		518		573
Dilutive stock options/shares		26		8		30		6
Diluted weighted average common shares outstanding		8,789		8,710		8,793		8,707
Diluted net income per share	$	0.01	$	0.05	$	0.01	$	0.05

XML 28 R17.htm IDEA: XBRL DOCUMENT

INVENTORIES (Tables)

6 Months Ended

Mar. 31, 2018

Inventory Disclosure [Abstract]

Schedule of Inventory, Current

Inventories consisted of the following:

	March 31, 2018		September 30, 2017

Raw materials	$	797	$	761
Work in progress		185		135
Finished goods		244		228
	$	1,226	$	1,124
Obsolescence reserve		(226)		(211)
	$	1,000	$	913

XML 29 R18.htm IDEA: XBRL DOCUMENT

SEGMENT INFORMATION (Tables)

6 Months Ended

Mar. 31, 2018

Segment Reporting [Abstract]

Schedule of Operating Segments

	Three Months Ended March 31,				Six Months Ended March 31,
	2018		2017		2018		2017

Revenue:
Service	$	5,030	$	4,962	$	9,555	$	10,226
Product		914		1,397		1,766		2,307
	$	5,944	$	6,359	$	11,321	$	12,533

Operating Income
Service	$	244	$	445	$	426	$	739
Product		(134)		110		(305)		(90)
	$	110	$	555	$	121	$	649

Interest expense		(48)		(134)		(100)		(210)
Other income		4		1		4		2
Income before income taxes	$	66	$	422	$	25	$	441

XML 30 R19.htm IDEA: XBRL DOCUMENT

STOCK-BASED COMPENSATION (Details) - Employee Stock Option [Member] shares in Thousands	6 Months Ended
	Mar. 31, 2018 $ / shares shares
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Options (shares) Outstanding \| shares	140
Options (shares) Exercised \| shares	(2)
Options (shares) Granted \| shares	198
Options (shares) Forfeited \| shares	(13)
Options (shares) Outstanding \| shares	323
Weighted-Average Exercise Price Outstanding	$ 1.91
Weighted-Average Exercise Price Exercised	1.4
Weighted-Average Exercise Price Granted	1.94
Weighted-Average Exercise Price Forfeited	4.46
Weighted-Average Exercise Price Outstanding	1.83
Weighted-Average Grant Date Fair Value Outstanding	1.45
Weighted-Average Grant Date Fair Value Exercised	1.15
Weighted-Average Grant Date Fair Value Granted	1.52
Weighted-Average Grant Date Fair Value Outstanding	$ 1.45

XML 31 R20.htm IDEA: XBRL DOCUMENT

STOCK-BASED COMPENSATION (Details 1)	6 Months Ended
STOCK-BASED COMPENSATION (Details 1)	Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	2.31%
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.00%
Volatility of the expected market price of the Company's common shares	83.70%
Expected life of the options (years)	8 years

XML 32 R21.htm IDEA: XBRL DOCUMENT

STOCK-BASED COMPENSATION (Details Textual) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
2018 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	700		700
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	$ 250		$ 250
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			1 year 4 months 24 days
Allocated Share-based Compensation Expense	$ 35	$ (3)	$ 69	$ 7

XML 33 R22.htm IDEA: XBRL DOCUMENT

INCOME (LOSS) PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Basic net income per share:
Net income applicable to common shareholders	$ 55	$ 417	$ 81	$ 434
Weighted average common shares outstanding	8,245	8,148	8,245	8,128
Basic net income per share	$ 0.01	$ 0.05	$ 0.01	$ 0.05
Diluted net income per share:
Diluted net income applicable to common shareholders	$ 55	$ 417	$ 81	$ 434
Weighted average common shares outstanding	8,245	8,148	8,245	8,128
Plus: Incremental shares from assumed conversions:
Series A preferred shares	518	554	518	573
Dilutive stock options/shares	26	8	30	6
Diluted weighted average common shares outstanding	8,789	8,710	8,793	8,707
Diluted net income per share	$ 0.01	$ 0.05	$ 0.01	$ 0.05

XML 34 R23.htm IDEA: XBRL DOCUMENT

INVENTORIES (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Sep. 30, 2017
Inventory [Line Items]
Raw materials	$ 797	$ 761
Work in progress	185	135
Finished goods	244	228
Gross inventories	1,226	1,124
Obsolescence reserve	(226)	(211)
Inventories	$ 1,000	$ 913

XML 35 R24.htm IDEA: XBRL DOCUMENT

SEGMENT INFORMATION (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
SEGMENT INFORMATION (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Segment Reporting Information [Line Items]
Revenue	$ 5,944	$ 6,359	$ 11,321	$ 12,533
Operating income (loss):	110	555	121	649
Interest expense	(48)	(134)	(100)	(210)
Other income	4	1	4	2
Income before income taxes	66	422	25	441
Service Segment [Member]
Segment Reporting Information [Line Items]
Revenue	5,030	4,962	9,555	10,226
Operating income (loss):	244	445	426	739
Product Segment [Member]
Segment Reporting Information [Line Items]
Revenue	914	1,397	1,766	2,307
Operating income (loss):	$ (134)	$ 110	$ (305)	$ (90)

XML 36 R25.htm IDEA: XBRL DOCUMENT

INCOME TAXES (Details Textual) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
INCOME TAXES (Details Textual) - USD ($) $ in Thousands	Mar. 31, 2018	Sep. 30, 2018	Sep. 30, 2017
Income Taxes [Line Items]
Unrecognized Tax Benefits, Beginning Balance	$ 27		$ 16
Operating Loss Carryforwards	$ 1,600
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	24.50%		35.00%
Effective Income Tax Rate Reconciliation, Percent, Total	(224.00%)
Scenario, Plan [Member]
Income Taxes [Line Items]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent		21.00%

XML 37 R26.htm IDEA: XBRL DOCUMENT

DEBT (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		9 Months Ended
DEBT (Details Textual) - USD ($) $ in Thousands	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017	Jun. 30, 2017	Sep. 30, 2017
Interest Rate Swap [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	60.00%		60.00%
Huntington Bank [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	5.00%		5.00%
Amortization Of Financing Costs					$ 56
First Internet Bank of Indiana [Member]
Debt Instrument [Line Items]
Debt Instrument, Periodic Payment, Total			$ 33
Debt Instrument, Interest Rate, Stated Percentage	3.99%		3.99%
Debt Instrument, Face Amount	$ 4,500		$ 4,500
Long-term Debt, Gross	4,335		$ 4,335
Debt Instrument, Description of Variable Rate Basis			less Twenty-five (25) Basis Points (0.25%).
Line of Credit Facility, Maximum Borrowing Capacity	2,000		$ 2,000
Long-term Line of Credit	0		0			$ 0
Debt Issuance Costs					69
Amortization Of Financing Costs	4		7
Interest Expense, Debt		$ 82		$ 103
Payments of Forbearance Fee					27
Additional Forbearance Fee, Indebtedness Paid					$ 100
Unamortized Debt Issuance Expense	$ 57		$ 57			$ 64

XML 38 R27.htm IDEA: XBRL DOCUMENT

ACCRUED EXPENSES (Details Textual) - USD ($) $ in Thousands	6 Months Ended
ACCRUED EXPENSES (Details Textual) - USD ($) $ in Thousands	Mar. 31, 2018	Sep. 30, 2017
Restructuring Cost and Reserve [Line Items]
Other Restructuring Costs	$ 117
Restructuring Reserve, Current	1,117	$ 1,117
Lease Related Costs
Restructuring Cost and Reserve [Line Items]
Restructuring reserves	$ 1,000

EXCEL 39 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 40 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 41 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 43 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 39 159 1 false 10 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.basinc.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.basinc.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.basinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME Sheet http://www.basinc.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME Statements 4 false false R5.htm 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.basinc.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 106 - Disclosure - DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION Sheet http://www.basinc.com/role/DescriptionOfBusinessAndBasisOfPresentation DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION Notes 6 false false R7.htm 107 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.basinc.com/role/StockbasedCompensation STOCK-BASED COMPENSATION Notes 7 false false R8.htm 108 - Disclosure - INCOME (LOSS) PER SHARE Sheet http://www.basinc.com/role/IncomeLossPerShare INCOME (LOSS) PER SHARE Notes 8 false false R9.htm 109 - Disclosure - INVENTORIES Sheet http://www.basinc.com/role/Inventories INVENTORIES Notes 9 false false R10.htm 110 - Disclosure - SEGMENT INFORMATION Sheet http://www.basinc.com/role/SegmentInformation SEGMENT INFORMATION Notes 10 false false R11.htm 111 - Disclosure - INCOME TAXES Sheet http://www.basinc.com/role/IncomeTaxes INCOME TAXES Notes 11 false false R12.htm 112 - Disclosure - DEBT Sheet http://www.basinc.com/role/Debt DEBT Notes 12 false false R13.htm 113 - Disclosure - ACCRUED EXPENSES Sheet http://www.basinc.com/role/AccruedExpenses ACCRUED EXPENSES Notes 13 false false R14.htm 114 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS Sheet http://www.basinc.com/role/NewAccountingPronouncements NEW ACCOUNTING PRONOUNCEMENTS Notes 14 false false R15.htm 115 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.basinc.com/role/StockbasedCompensationTables STOCK-BASED COMPENSATION (Tables) Tables http://www.basinc.com/role/StockbasedCompensation 15 false false R16.htm 116 - Disclosure - INCOME (LOSS) PER SHARE (Tables) Sheet http://www.basinc.com/role/IncomeLossPerShareTables INCOME (LOSS) PER SHARE (Tables) Tables http://www.basinc.com/role/IncomeLossPerShare 16 false false R17.htm 117 - Disclosure - INVENTORIES (Tables) Sheet http://www.basinc.com/role/InventoriesTables INVENTORIES (Tables) Tables http://www.basinc.com/role/Inventories 17 false false R18.htm 118 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.basinc.com/role/SegmentInformationTables SEGMENT INFORMATION (Tables) Tables http://www.basinc.com/role/SegmentInformation 18 false false R19.htm 119 - Disclosure - STOCK-BASED COMPENSATION (Details) Sheet http://www.basinc.com/role/StockbasedCompensationDetails STOCK-BASED COMPENSATION (Details) Details http://www.basinc.com/role/StockbasedCompensationTables 19 false false R20.htm 120 - Disclosure - STOCK-BASED COMPENSATION (Details 1) Sheet http://www.basinc.com/role/StockbasedCompensationDetails1 STOCK-BASED COMPENSATION (Details 1) Details http://www.basinc.com/role/StockbasedCompensationTables 20 false false R21.htm 121 - Disclosure - STOCK-BASED COMPENSATION (Details Textual) Sheet http://www.basinc.com/role/StockbasedCompensationDetailsTextual STOCK-BASED COMPENSATION (Details Textual) Details http://www.basinc.com/role/StockbasedCompensationTables 21 false false R22.htm 122 - Disclosure - INCOME (LOSS) PER SHARE (Details) Sheet http://www.basinc.com/role/IncomeLossPerShareDetails INCOME (LOSS) PER SHARE (Details) Details http://www.basinc.com/role/IncomeLossPerShareTables 22 false false R23.htm 123 - Disclosure - INVENTORIES (Details) Sheet http://www.basinc.com/role/InventoriesDetails INVENTORIES (Details) Details http://www.basinc.com/role/InventoriesTables 23 false false R24.htm 124 - Disclosure - SEGMENT INFORMATION (Details) Sheet http://www.basinc.com/role/SegmentInformationDetails SEGMENT INFORMATION (Details) Details http://www.basinc.com/role/SegmentInformationTables 24 false false R25.htm 125 - Disclosure - INCOME TAXES (Details Textual) Sheet http://www.basinc.com/role/IncomeTaxesDetailsTextual INCOME TAXES (Details Textual) Details http://www.basinc.com/role/IncomeTaxes 25 false false R26.htm 126 - Disclosure - DEBT (Details Textual) Sheet http://www.basinc.com/role/DebtDetailsTextual DEBT (Details Textual) Details http://www.basinc.com/role/Debt 26 false false R27.htm 127 - Disclosure - ACCRUED EXPENSES (Details Textual) Sheet http://www.basinc.com/role/AccruedExpensesDetailsTextual ACCRUED EXPENSES (Details Textual) Details http://www.basinc.com/role/AccruedExpenses 27 false false All Reports Book All Reports basi-20180331.xml basi-20180331.xsd basi-20180331_cal.xml basi-20180331_def.xml basi-20180331_lab.xml basi-20180331_pre.xml http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true ZIP 45 0001144204-18-028903-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-18-028903-xbrl.zip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

R(3/A9E098 MNW9:DJ+ EIC]*DHIHXG!DK56$N#LVO%(B !;,O8\;?S7.(K+/4C/C[HB@-VY MS;D!(&RIW5?#_1+ G\<1R)V!Z*M(A$]T$C-:R$+Y)8AB%J1OB]X)*V^YE=EU MXR\T?8Y]_G!7DN;A#^M]I\/0,THU?8?/\1+]F7!$WDXV@<0._4M6F0"&[=J2M!Q%; M7GM3%+IYM5([H H$!\UZ!#;K# 7XV%+G2R#,9ZPJUVJ_Z"SOXUB3MHW#@<(G8M1+0MT.K,_TCN:YV[R?-E M&']/=O%BEG/:V2FT[LTLQ^K3)56O9N4*%(\"D=P_+V>MW]AP3FV:#IKZQ- CP;-G5[0 TZ[D5@.&BWX]C3 M$[*;;Q<4CL%>D =I\ #5*7<8_IG_5]&-%+4 )0)?N3W^Q/U%JQ!DM^P6SBJ: MYW"!79..<7$%P(; ^K-MLE6Z0'9_+T?,M\2"W+X*ME75B#- X$[?-N=ZC:"[ M"@AJY&JXB?@%[)L)( #HZ=MMZ$8I#ZY[F:K37ILU . 1Q/IONSM4T0VV"XKK M5NV"$N;OF1EL),T; 24@"!?8=@>IJA]L%R,WY=],"5^I>VQ6!^ (# 15B3*E M6X87VW7+3-]\;+'=A]V4_!S.1K!*L;'_RA^"JD;S>F7B8'@"RQ;) M8K38+LV:>T-:\?F"$A#8!%OW'59"C^U*JD3^V57:EMS_BL9 *3@O\U1W_VM1 M8KOD"MN,W-)U&3/ XE'JYS>JX6<_XQ"H=N=NV + 1V#;JTN;Q-)?!3JV.[5% MB6>6Z2^N]PQ]G[W!$._HR7[9N)M=Q]/1 V?2" M/JH(EE4!@ C,;W6)$=.LQHKM O#M4E8N(W_7BY\T>29BDRV;H!; 1&!V:9=2 M+5QL5WQ+?1#F)GXYBU%?F21(6HD&@>NM;4!<@(;*+V^%6 5E^3Q;%5FEN$ MK[F)]^8Q#)YF2>LJ[IXDK8 :\!Z56MQ0*>%+>D&7>> ,U='*&0F4@.!LU&X? MJ(I>T@6ZNW@*PO-'3.$?;MMY=4/>G\4W_Q6=H$HSH @$7NYJ1^3J^"1$=W=[ M58A@#+V7L3?HJ-J7V$WJ W0$9ZPVJ!4"DW#:W1.$V"6;H<46764FV"(_-62-^QN0=29C^JP(9D MT:R*\V>VI/7<*?V>32-7M6Q)5=F4= HUUCU+I=3O6=WJMI!**=>Z9*,CP;-G MJ90 TZZD4JI,%MI42DN,G[*$>S*2^]E"0I0!JG3Y<$ZPM'G73;7>) M??CS>MP(R'WN091;]+^4[(W"YY$D=0 J H^D9D1)SA!J3-C2[BQW O<>C5P6 MQ*9GAV)Y@&8SCJ#3,\,F3FQ)<182?HN2%^H%DX#Z^OVIK [IGR [1&P2(+.4 M*B%ARW#3.FNX%L!VZ=,N>YW98#ZY(8_POG^F-+WFG^&J5D^ALBH =-\.%FJH MV#+-B*35CDEY)>[7P7&J4--@3ET)%[9$,#;8PS6G6J!1.['BL-_,CTZF1IMY M<=+O(0AQ;NP"ED/#EL(E3Q:U@5>U%DIJ\%>Z$40F-Z9.#0];>A911SO/&%-? MS5?4(D[O%,&%,"LCL Q1G69E.Y%,<]M\(:1R'LS4R2-K,V'NZ O/.1\]%:2Z M-GEVS: Z.>UWMCJM]L<*23^]S?]H'LQDW!HY<;I[TLV8'-E1KR;;!%LO[) M8IQ.')O;4A33IASW7L0ZG=IU$+84ZY3K6T+4)IR]B'4")$AGR<8,68AUXF?Y$,T4+ M"Y-3JUZ;5A6M ( L/.B.OM(H4Z8Y6!0AIQBLO$W/Q&4TV()[ENF%C1YP%90& M6 CLN4U)D@+#%M6SN&TYO]6HX&JM),!!D&:O*4]"4-C"=G+?P->XK' 091!J+/9XTX2CY1T (MO+WS)8AB%J1O MBPX[COQR*SP!1OKVA:;//*T)OX^=;UV5 WIK4@"!>+8^#2:++2M,'<*T)5\1 M-_\\KC\6VZ&_:/'R4%&<,6-N])2?W7X/TN>KR ]> S]SP]53MXM\FR8^I;8^ M00:G'48-+JQ%#=&8NZ3:^! 9G-@TURB]5>W2KO-HM:>M?7!VC;^[S.=A]!IK M;:DY@ZEIG6V/6'$7$J@ F8]+_,!X00?)I[<-X#FL%;;(YV\1?W6G5&]6 MM/ Y&,-6=RS&9F,!VY*9Q9H6D'GG]J1WX;)]=][-T/H5/T]?POB-TD**8.UU M-6D=0(HA&Y^UJ4+<9S3JP.9FU&E'IIQY_NB;+$U2%U;XZ.EKINDHK7\+-(K MQKV5G;0=U6%SK?(APU^'H/Y%'E0Z2UR;(TNJIGFOWACH!(&-<"O=J:9ND"6S M:#HJ?H6":7(5S=#_RM3^&PM?(X,!@A5R%R8PJ?*0Y=]HBO,R9A,:I!F,PP58 MBUU2\#70*H*[";O0):7*0Q8TT.+>X7<:/#VGU!^_4N8^T<7J<,L"3VDUW8X$ M9(#A%=M=Z+J5%(HMZJ+^@6YM4[,Q @0[KZXZ>$51@! $&;QVHI?7TFQ[P4^R$'1K M.Z]\5%^X*;UT R9[Y6CK,A#G^&S/311=Z;2]G$V6^NK2^"<9?]OKL=4E(0,, M[SBB[[9U%8LM1U6[YL4Z_;PC2"()2.WR1J38AUR:93AHW M3H:#[JYGKVXOU]X&5\B.TNP;9-A=%&I;-.OB3UM1T3Z$GBZO_(KPG2F+4ZD _:Z%2.Y "/;0;L+)F@'^.=MMFX]U6L 6 M\[@?O0O7*M-Y-T/[_E>[ ?[#4PQ/K%N;*B0[$;4ZD 4D+G!I-B'%8H##ID$ MWQYD$SRR$#[CZ7VC%UL-:#=>]C<5K":B*#ZV\+,&7.!:).N3HGT>H4;8E,2' M^? ]?GB.L\2-_,^YQ9Y&LY/@5>3!^ Y>*1=/G:"L2AO$Z8T0!)&*!H+ _5<# MVXN^LEP+R$)O M]J1WX;(V=][-T,8)M9QSS4%PP=#>5%'5)9NK8]<"BF3*65Y.&"=)-IU9HNZ" MY(]+1NDBZ?8=G.ILG"Q,OTT&/03^$\L[Z^TH<=5*1!;Q9 7U;W$(S81!^M9%QRU_G3B]L_TP6&Z[[PKU MB"Q^*T>U8?G1V&*0' O>PM]U:+VE,%IV[''K]YUN:4L M!]/A(RG+.R5&IO6-PF1PTMWBM)!&:^\N%021NS-:2Q0H&0L"N??!DMSN>_6# M$YN38C4+LX P#;5B.,A,QDV?.1^<6$U/UL)3]+G6Q53)\" SO+; $2ZC9XMD MX35?NBP*HJ?E1@#V3($W?DQ2YGJI@C]E/3(X19 -L-I29P (F2'R*TU7&[GQ M*^S?^)S_$,.V=1I'>0=\CD.0,DR6T*,[<*@ M<-682[RQ=(S]OV>S9Y$-1GG#ELE@B' >K]!!6L&/+?,[='F6SXIY[#[OZ+/[ M4VG*@L>16NFQEZI2M6%+Q?WINU_TXPV.;88.5/+<*WJHZ M<'-4>^; '1Y;W6BVX,#-M6[L$\SQ[)D#%S#MB@.W,EEH';C+>>/._?X%X++ M#8T6YV)Y0(A@&U=SH=L$@LQ1NY3T]YC]<17=LMBCRK>JQ17(T$%@P:E)D@ ) M,I?J4M1+4&KR3/U?X]@W8JE4 ; A<,[49$F !)D+="FJ[KWW=^67+,NF,.H+2 M9-1=ZABU0L5=6@IA'\PZ97 :>\YF85 $FA!\*4\FM*[ (+/?E,4TRHPAJT)& M=B_K&MMR9*HW(6H=#C)33LMTX3+KM,<;6JL.7Q)N)N>,^D%ZZ7KY+5?-K"BK M KI!\QY Q;E1#0F9E4L3I80A7K,V((3YDQJ&EO^S>HY'+@MC4 ML5XL#SJQ&9=L<[^AP(,M+'TAX;:%>, FHKT]5**M#1G;#.*M[US<)D#"F MAH0M.KQUUG!M)-JE3_M.46?&D,L@/U-R71XK[1OAZP!5#O M:(?"M5P@Z%G:-:8S<](%9<&KRQ^!6PG.DXUJ?2/R:@!X5RV!>ECJ=TZZY.\\ MCO)K"+Q#&ECAY=6(XUB-0J_B.='1H:-1BD["8V MQ34X/IOV1:M6*B4D2=Q =X:J36GU)@]9'1X@8]4L;&ZI4I)@3%P)EH2Z[JQ5 MK5.':]%KGT/=:M?KS&15GF-FST8&WOR^NG%4R%H],L*0#KIY,)T0EH1!)"$] MI66;FUWY4Z#\U7#WR3P.4M4(* '!1?WFW.HQ2HCNS+94EO_2]>AX&F<51NFJ M"AEAR-C7G,1U1!+*.C36%*4]=QE[XZE&JM%6KD9&@[V86T6H)/1U:*LI2GQ! M$X\%N70WD]]<%O -.9\^>*I!\[AD=3.@" 27*IK3:X)20G=G)IUK053'%_=' M,,VFGV+&XN_07<_=%_A+^E8QT$O6#"AB1U?3ZB@E='=FZ"DB,*23C##DUFM* MUPR%A([.;#@-]L:MT-&9PAN MY=:=;BO"E-Q%Z,P$!$L_2X,_W=DB,7?(P:RA(5A5C3C'(P29Y^H0:@!+0F"' M22UG9RC^FE&44([:P$Y>*,T5LJ-TR=%(6*IAXI$$U\[-$=R)';-'ZC(^SF'H MRX)J9>6)T^OOV#'0!(]$_S4,-!+]CWT_F+5>_OY5Y ,4ZDZ8H)35P2T(Q0.P>ISG1$P"8U;3HK( M$XL_N#^621%KW:>7C/M"ZTN]R<:XJ"Q_BK*&*4HGC>R.NZ 4&?5M+K?"N^TZ M=0@F$)'0^W";?8EKG*7/,=/?W117 (5T?JM=RI-LMR0'@NQ&^Z:H6N>FK K@ MP_&\G$K]IH05(2&[U=XR9;B\T>URA_9F.X@[LT[ECH%)S/C3N9KI45J'C$YL MFG5LS) :+,@NM0NE-4HGH:D):'$D ='P48'$=7#(KK1;I1+75&J+4PL7VEOC M=A;#HI](5^4 D=!VQ5GK#79L5U(S\73WGPHE.*V M7*MQ2<;SU)IF%>HO28[M+GD]!G!-3;6HT,Y)G9D9VDF# AAMVF!M3%8J(-AN M8+>;2L/IG>&PX*DHD)"F 87M8G/[Q.&:#-MF4#M/=F916,A]&[J1=@7;+,S1 M(0B*U(T?-6<;<+#=7_X6,>K%3Q%WZL(:\(E&H&1EW)6D!JSM'48L5_,N&D'! M=B'Y!A9TE^?QXP]F%XU0*K+DE3*AWNS6_!PI#WV_ M@SX7\4CI/,9OG%Y2$-,-^<*0\3<)2H45W+;0.G&.^S8])%9Z07NXL5V&%B/C M-_:#*..9;&;]/XY40]Z\$:Z%#D.1VF1? 4]];5H8D/3+$?\TR$=SU?P_4$L# M!!0 ( '."KTS"MRIYT3< 'XL P 5 8F%S:2TR,#$X,#,S,5]L86(N M>&UL[7W_;^0VDN_O#WC_ U]R6,P [9EQ)GO)3';OT+;;6>,\;L-VDCT$AX4L ML6W=J*4.I?:X]^'][X^DOK0D?E=+)#VX'X)X["JJBOQ4L5@LDG_Y]^=U IX@ MRN,L_>LWQV_>?0-@&F91G#[\]9M?[LZ/?OP&_/N__>__]9?_GC[W;MW[]_6A-^4E!^?\[A#_>5]37O\]N^?+F_#1[@. MCN(T+X(TW'.19GA\QQ\^?'A+_XI)\_AC3ODOLS H:%\>$5SQI4@0 M>DOXWZ;P@0P6^<('\H7C?R5?^+;Z]65P#Y-O *'\Y>9"J-"'3EL5TULLI2TY MKR&*LVB1#A.XSVU?\MLB0,4!LK?Y;4I_EQ5!,DCN-J=-B:_@L'[>\UGM7^PT MX;#^;7&.+7'!2FOJ/J8LDS69A MI\&$..<,=?7%/C:F$]&[]Z6'_9;\YA]G6;A=P[28I]@Y%'&QNTA7&5I3YSZ_ MS\FT5-0-4?%I\_\PX*VUK_7OB(I@GFU1"(UT+WNU*U-P;R(3GO,P)YG:87KT MR^TW_U:S +!U453I1?7(8OGG(GMY&,,9Z'7]/?B"(^_[HW7$U MJW^+?]5(TA+@+KC?VV<+9G)R:\A22"T$4P=!E-HA?'2ZOD:,?K^;@F05Y/=4 M]&U^]! $&X*4']["I,CKWQ#(_-""3/7K?^#YOX!$H-,DR//EZK;(PL_SYSCG MX$:#QQIX=.3O(XB2@&P%*!'V/IC,(72TAZ#&CV'_3^UI[G"S"N]2DCCQ*)5T M0B]"_NZ'VVCW(\]5L)TXUYAFZI*NG M1L1YG(=!\I\P0.?X-[S)7TKM!!6LS$)>#M^!V,NLK)#T\ M%0CN4$!J VYWZ_N,Z?Q*AQZ-U8'OR]@9*!E!B],''Z$S1ISP M0GN '.QP+%?G<1JD88S71UD>*_9BS=C=[7O(M>HCL&$CVR -(Z@YO=B1'3)P MPBT2[5%S $C1_JR(T!W(1'NR>S@YWXB5]ZX0'TXW7]O[=V?9.HA3"1IXQ-81 MP958M<]:$GJ #7%_]_&AZFP'WN(R3N$%_E%K9[Y%[,YKM"66> Y"!BB=!Q 1 M=[?0A0CZVAY$YGD.BUPCEND36H<&(RFS@TL)E&'(P8(^072?-66.A\KK'K9\ M"/0A*QM_VW"MLDW:J&7H'8&7E9N/B1FHLX)^@5DM?RUW0.D_^@)N 6#X&)>B MQ6* %^2/\S0B_UO\L8V?@@0+E<^+TP"A'5X3_QHD6]D*0)/??ABHJ1<#+

=2)U-LPI#GLJD3&[AP]QFI)!P_%^ M*N$P@R(0?QOCSP[0&FI1GIC3$ MA/RU&\$&(Y8_A32!'R1)]H6<-R;_^)?O9N^./Y"YZA/&^R-X?SP#](@TF=+P M'[]_]SWYXRTV +B^APB\?T<)?O#;X(88FKF!"<[Q_9+>QTD"HQOX!-,MQ)/F MLGB$2&PS6EQVS^XI=>ACK&8 %0<]O4=YW)K,@=J@DB.G]I 1IHG4B*I23'JX M:[I1">I147@R:X&G^ M3&>[B:!>M,Z*'RIH#',ZL4TE:NO:@!%$=3]I\E#:GR3%$+5G3=<(;H(X6CQO M8)I#=;@IH+=N7R*Y^Z"HZ$!%Z$E<:2H]+ D]P+44+WV :X#%)M*S#43%[AKW M,+T1X(]MO"&1@'P>D;,YP+U4"Q9 )?D,4 8:EC0L4\X]VH8P2!VJ!]SKX7AB M,M0"_Q9LN)KX8-]J*V'-7-=$[%G[)0QR>(%53HOX";:6H;@;E).<#K-UR]?2 MJ \UR@0:KFZ:I6%TZP,.4(PF67U*3NK#KF]$IIBS9TIG< 6Q !$6+EO#N^"Y MW,253YLR)NNF(]6 .7):$8.2&F!R4!<-.)\OAVE28!5HO8![ U&#J6\8NDBR M9Q _9UGT)4YX1V!8$NM@;TG7!T3])[<8=B>@5D)$0SP:< I*;PX6TJ!F0"+J M29"0K0?7N_U#);3IDOKFW'= ?%NV&,K&P7VR8-R636<) ;B6:G* M=; C2U3](I4^@[/R%$9R86%*1>G)QH&Y_)N2TCWPY: 1%9#($&,/\#<0&]PV M++8H3A_P/R!ZTD"]E,LZ].4Z]/'3H085N2=&<(@F]63@0>"D :J^56@CRNI< M@+8P8B<%8"W\VE948XLP..@"R>)1HFQ?9 M&J)Y]$22&AHV(.2P?UQ(*#L;49>4H";U!/T#- @J4O?@5T"'.1ZB@QOK[K]) MSANX?QZ/*_?/E5_D./<;0]Y8@(D:E?@%H?)J>2 'DF .4*'(YG'234R*1GH 8\]9ZB/.N=&I%6VH\'KBRE):ULDUN1+S Z3+;WULW;IGP*2/BF$IP2L[668JQ11E7C6TAPZ)"0@SO,M/7@89OED=QMH M%5,8*0FHDK3BUKWURVV%V:/1,!2KASK*FBFZFZJZQH1+[>) !T=FSH&(JJ:M MNI^5$L[ !48\G.IN"_U#'48:T$U]J-Q?]"HX@NSI MV6,)DCF'3>0PMAC$[B_:5=XAQ)#:#U%9:9G0K7,GL@V;TYI=]"7GF].\97D? M>J;W$_AQ]MWW?YZ]_^Z=F241MO>S'S_\JZ\V)4(G$\9*H6DQQ1A%]&;@(+D. MXN@BK<)K68)1Q&$_O2B4G4DN-I2 D((X!17Q#-R)0R)K"<8ABI##?T=8D2IU MXA[Z"B@Q*48='-FL0BB".(71(D#D3J]\'H;;]38A4_X97,5A+"]&4#,[J$G0 MT(C=T"^90,T%7K7X0,7XV@NS&:1@6YNHI')O.OK@8XL6S)!G\_;F?K&IQ(!X MQ YN;^9(S-[>O"?ZT[?O/_Q45T;/BP+%]]N"[/C@=3:>:! ]/CNEH6@=H-52 MBTII7 I]L (&YS&TU/#D9,;ALMJ]^%MDJ>S%WW(S=5(X+DNQMJE0J$1U5.,M3!B*AMWBNJJ^G^X\0V?9]KY8;1/VWC:-<@ZS=NRO MP0SU9,*QYAZ_589 W0+@7EWH_*ZO@P:76?\,'UE7R>[R8:M]8D<[[\TR.DZ! MTJP_&SV>9*F\4QO#K2*X%U11<+LJO? MW6&*'0.>^*-A5M(R1_N MU.;T ESRISM%"//BV4[#(=+!F@B;6Q'UK-<044FU<2=NP#'\ M))HI44BF3+QD*+G+R1-@_A*=O@%2-81R7.J-GY,M>*TX34#O&J%U=^3] M"L^D?2_9978?F#$O)&LM)*5<+A&DL83DOG;MT_I18T@DD/)EY#)7E45U&]SK@HH>5!/%\6 MEL7I0F/U/W1&Q^6(' M.:+9O,BL<7V6D,/!.QXBV07':EM/9RLNS;()),40L"]3:/2_1=\4)#"O7J'! M^'Z*0ZBX?EC(8=\G"65G_!&AK!\0FH&:N'H/;=(:'9UB:P-%RK_6;SJY1[\" M/XP+U0&/&_23NT@-H+\G=XK[EM0*T%-*'Q$O4>$:9=$V+/R$>Q\P,JSST>(& MZ/H8=P]O/BP:3$\/9JT22Z7 92&5ERC6!+!#[)YF>;%)72P!.]) MRBZZ!^ >%!(KRUU[EOPP4<&FQ(0P\(VBND\<)LE\O1DC](1CMNRBB!! M:0 A\@C*.H)O?(LL!/C@@UD #B=H)C>+5[:E#VR&R27&60WD<"='46L&"]C7 MBD&,U"G#D;!2RD<3$(!*8@U21%E\P 9E>8Z7+2OIB<$.E?UG;#HR,B^QD+^" M\L\> %M'V W]LWL ?%$-/+V(+K<0!04PWP$L!M_XN&W^E(")'>BX$CG#(=L248?@E6#5\'GXK4$J1Z< M5P8H/8V[6QS[A\<]6'D>I%2TYW!O$EHPX[R>H(LQB[$X3/&$DV"9YM$Z3F,R MV9 78-4FH^2T'[,K=6%"XY*# JS+XY7A'*98T.%Q;SR:D&-6!29X<[A2,%DA M^+ RT%H1>+#(U1&\3-IDS$K />B%,%$N )P#NZS&N<1K M5='4*T(X\8U-9AC7E#^F9)ZLT8UD!J\2TN<^+=%9G MM4P1RFT6-!<2#JK&T M82@=%#'V966+%TN*B:.N#Z6\*7P@!\54P#80&TZ34>C*>Z=3-#26T':K0[E8 M9JM")4"V."\6CQ!=96G6=09J0U0QVI\M59HP3IPP@#9',X-63!-/HAO,A-?, M]$&#G[=Q1"Z'&5]!+V;5\46W.JEJ&0DSOQI8B.WS V2R/\=ZGF8IEFR+A:NB M@2S-3^ J0[#U%-2G.,U07.QJEX47K=U6RJOA/L'B,<-_><(D)!Q% 'L9P#T5HK[/LFP:M-J>]1YG6SP7*,A0%*W4P'GQ:)4@O@^P0%_.W9+Y[;M-*H/3KKMMJ7DS='=Z,E;R_U MUE'%AY6>OIQ5SM3EF;1#.]6FQ^#:7-]/2 S.-"\*>OV/T#;/ACK)D#5 M!B@;H==],%?F-S[#F^.(8_9 V'X9NOVNLP$TUBS8,^UMCXZ6>GBY@"/ MX]R]5K.[R77BQBWYXF(ENHX3(WGI9@VTGE8-K?SF:$J +R_?#:F,4],1Z5FF MS2?7JSNEEZO3('\\3[(O.E>[R-D M_?>V*O>]RVX@Z:DX@9U"H;ML/".?YG/VGSF?IM>8U]#WGR&;X\V' %N9B/_\ M4EV*F\Y$36>V-@OP[\F_0M*3FU9/9GXZK"F-EWF??G++M>?TSN &#W],CTN0 M*U;6I&CHG_2?$M\EY;+N@N0Z,(NU%C5>1L-- FDI(+T+J,5*#VQ55R'3?SI_ M&&*XGN5]0"UZMVYN1$4\<#T:)M3W(-KV8W&%7-5(P(@4/L$T5_D $8/]5;%( M[#Y3CH./7(LP'F&SK+M?;':)O,PS+;RT^9R-@=OHDNUX#R) M5)*#589 S0!J#K<&?I N4:U+,*TN1KMVAAJ=8@-YP$X+KRR\,7$=,V%?H->U M$8O7>09Q2M8=RY0\3+1<81GQ6J/87>,1*,B99GKGJ,3P=1NP?[FGKF;,59B8 ML4X)8"LZB_--EE-HDW1XW0R@[8"F(2]NH#I,9ZQ@1)4E5R+2UUQ*34GH#&MF M]Z9G!EGF5M !>+5Z;!]!' J%6SOP88N/O47-6$-WFY@[3%\U[Z '.B82MYEN>P*)_+2>+@/DY\2:290Y=S M!'\0;EV:9SU_W\ 0QD_D"):18?+8/3!)KE::QECS@CVSZVL9!ZG7Z($4>K@U M,C$ U>:E0I]+PR)WZ*3X:['T@FP%GP>FU-5#TX9:3%[$E>9J-7_UT68XV%(; MBQ!8;JVDN:'J.M@1"Z9'35N_'C@QF37LA9T9]82V(>YOYP-5N\WIZ\X?IYOM M#HTX#^^9^FZG( S1-D@\M6ES2] Q^J%FX-(K7".X">+H#*X@0C"J;K2:IQ&] M^&%.5Q!&WD"O00^\@*;FFM9?M=;<+4<67>6-(65+GL[- SNAUK9^ X.JFU%U MRT6GCV9O G6UN9OCW(>U9^69!BT\&UX/C)?5QW3)V"Y(8E$DC'A\#XJ!PP/$?QU<+'Z:K5C6]>TLT1^WP4S^> M669YY_](!_:DC?EBJ7*-#2VV:0Z_.OPR'LZ;I:F/98HUKL*.' M<,XSA*4-(8SH$Q[7U9F-)ZA,D6JW8+_R55LW)O]7<=*ZT5$45QLD0_SIR$PF0+3(:BT6EK>R%06WWT*PL:6D1T6EAMCDE':; ]/' MF'646-7K&'6'LT1.SP<](BS[=D&^4TR[72*5PN9RD4O@XR-!%Z4#, RN%'@L1<%6(. M(*Y5"<6JN,B/2- ERHDHH>5HTL!K1/R_4P0CZ>N\$AZWTT9/?L6\0:CII9*4 MWJ,90Z'&WC)2@.!3ECR1\ NW3/,8H40;9Y,'#UC2V4.,*CHZQLPB\KDF)0FB%7 ]#M M$K[:';PD-6'+^R1^H%M]'7M[%NM.%EP]W9I MCMCAR6]G;W%C\>9I1/Y'=K:?@H0XD6N(XBSJ5U1+[-*L&?NO=9MIR1888:R2 MV@WZ0ZN%&2C; )Q# CX\VGV8VE?E1>"E8G%:FBSI!OH#W+?HWE2'P)AYZWLP MABU>T+O=;!+Z[$F0U,^>7*2K#*W+:X0U7K/1;<'^%;[:NC&WX;8X]V_<@!:S M-YO&(RD9Q7F89/D6E6D9HO**J!SOF_)@%]D0K M<9JE>9;$4?VPQ37&)!EC\L_EJE(C2)H'_'0J(D=JW[H_&:M?F!?C6NW.0*=E MZE/:;1-[:EH'^^:]>@)R5 #UK6H"]+P0T]I[B#OX7)Q@,3]/967<3[TL@^/W MUB2VUY[?R<< _9KCQ:F%SCM;W)[>7%S?72ROP/(@OG5 M&3B9WU[O>2@_$-_-,Z1C@ MMEG @[W+-BRVJ%STWL"$E(D8G9XS:,-!\8Z^?FSI3HN7&FS%;7(XSFY=B^%@ MLE4M@T;2XG9<^ BC+3DB+A"5GDVX4]SH:M2*_6TY(QV9'%_%319"8@#3)O $ M0QKQ +@#AI79NQHZIA;!6R\<3K8Y*8G.;^%#F?%XCF4U6 H^^P!5Z,% LOHS M]I68P >XZ0P$ S#]47 T?>-_0/0D3\EYJ^?Q;T;D-A =)CDJZJ4IS8*384HV*Q?"GG"_/LG402Y^X[]+9#V]Z*Q#1B9_'S9TVF%6[/XX&.58])&D.1 6R^ZRE&:NR$&M M.*5[>I_@^AXB"9HD//8+Y23R,Q5P%2UH$8/?2W+'.PDF:I1'(SLI*Z<%>8>) MKA@ J\5T*EM@JN3T#,&>-5=KOMM'"(M+\AFR8R^/),0LUFU9(KU@<0LH+:B) MO8DN5./0!Y+>(-C<3RCCG%_2? /#>!7#2+T^$?,XV"L0RR\*36>@1>U1C*$< M"S;EKS40UE>X-W"3(5I$K'$Z3,CB:MW+DUZP! 8-K5?;H*IA$"R,%6/@8I.S M+UGK,-;)KOJC_F:G06L.-SU-=)9M?K(8;;4T(X?@:PH/MT&-!UZ\'3IPU-UY M3;-B,BUNY[Y4KSB*A:R7U6 #E5O\_&EQ=0,)D ?XQUDO[8OQ%8[X9X8,N'H?[ &=2US=_ )YANI7YSW1YK=_N4-L[MXKF4NEW$*+PJXEN[X:;$[ MC^@$6JE#NLXE*8054%X?EA\& Z>*AM2CI@/(^R"/"^ AGY#?X8>HI# M6%?@"?=Q9,36 "25F(5+2;/ M 8)8=!C5M\5JI,D/;=AZN'!P3S#GN#O7M;2;[&XSSP!M]HBV"YH+>7W*SX^# MDGX$,B9$/+28D[;4.BF;@UOVUV:$?3&VT4R?Q=&J/!F_8V[OEJ?_<70ROUV< M@=/E)W(6UY.,[$@&,=@[Z%B#DTQN(UQ;_/9C -4IS1U-0!HF=0EB=H-SSK/I@QJP\![^RE?+636? JUOO0!GY&O7 M^>FF#C=)'9_I.MGQ-34HG3KT&UXXK:'],R0: .T/T UR MD75Z67\U#J9,HX6!@+)X&1B5 ']%46S?H[-_<5=/3N8:*@H\KP[[]@[.[%3Z-K/"!7P1JJZ^TG^9Q]ASQ-K_6135Y2P6O2RK/Z4]P_(688 M+SLY8.S9VF*]2;(=A*V@3'EL4<)C'?4R^1GH5K2=:-V#'3GML>@#47,@//+< M(L-@ZC^&^&F-QOWSRCH]PL3'&C&Q(B2^]*HP:#38&+MJ0\R\ %,Z#V)$EM6P MM:2^B?//YPC"^HF:FZ"0KDNG__;+,42#_AS=3F> ?)VFDV [E30#1 ) 1 #- M.T]$",>UX [ZF) =K4A'U ]& 23LB!?AU$P->#2?-\QZ7ZA+7#QO8%C Z"PF M+[FFD4V7R/_VRW:)@OZTZ!)K"4 MPM?F$36[N%%_%\,D^LH1H0?5'(EJ0[O[T[?L//^4@S-9K/"(Y$-$!I MG#Z0U\&I"AHUXV(6^UE0L?1,$K0B)0_=EV[%J]IMU3@P*5"M07"'(YT")@F/ M(J(PWF*P^EDBR>! <5^ABTZ+) QU5U6#L/:W S0]NCS*U6+'E\28;TO MW)OQ@48@KO$YP )-]POXQP?%Z MATG-CF5U7FW?CPTGYFS=)%AZ >G:JDA^N2WR H*Z_VBIJLR;XULM)Q4KZ M:X+$:W/:H_6]&2B_B -1^!"G)#P#-EZ[TGJ=RT:_5J3@59DN?=WN'-?O??FI M_XO(':L\T6B98CTWY"Z?5ZZQS)/#/3[G>;V^'NK<7KVV5F6+;>443#4JI4]A M >(TS-808+]1;NI\=&^86C!3I?LD&+-G,%>PN*#]>YGE^?PIB!.:ALA.Z2X: MK51^S)((HIR**S$AXY:L&Y6YKGU0XA9 V01X11IY#9IF0)&!LB'0;JDR0R]N MLQQ'_\H<@\TFB<-:\_:F:]7&1+I&I*9]"NVKV':E]C?V-.^TOA\3"%7 M;G:4)'+3EL=IY+V^8R22J]:F3247I.WQ$LGB'N $%E]59K6']>&Y52[0[5GW M;S!^>"2Q$0XQ@P=8;N]6,I6ID];F[SSZ[VU>4%^E#OH/;MFZY1_>%\QAAC1$ MU-T'":A;!U7S93"1@WE1H/A^6]2&03\8/T&P6*U@6$R_N- ZPC%^WUPGV_PC M:/=0&3( 8I8@($?3<&=AP\5?S,FH );[CX):M^X[#^T+F.^J 0<]CT,4KS)TEQ-6#>O[ M2L^B5U;!UKW"AP:PBL;]C&%5/3)J&,N=,EK?>P&1K&E_-;V0M\J3\KY! M/:]RN2^GJG-\)S"ZMQWJ 5Z0J^64MKCRM\:BO#RG:][;DWI>;G'==?<(P9?:!(.JPQX(YU%$.FQ%.NR)=EBV MJG/Z(&L9<)"#,$C";4+J^4DT1:IE=^0OY K\*,[#)".NH#JN3"[()W]]B]<3?W.YNWZDG?\:3E<+9O$IZ"&,7>G#]$DI3K&5)>K7Q=7=\N;B\6MES:A?$]"'TH> M;?D8]K(E;\/?_;,G MS6QQND4(_S3@X2Y5$PX?WE%J)WM2IV&>@8K=XW>X1M;4 X=@"%'QRSXF^'2P M4&A+I;-"Z-*[6QKTY!:N"?K6X]-2D]?WPGA:W/$.4'.I\683C]@=7BXE[RCM M%Y!^O80D[FXA2@1][0 B-\&73SC80'&0:*&D2^\.*#VY)8X%4X*&=-K;4;4/ M=.DI021?UW_W".<\S BA+@:, [3_EJ'/..Y&60BEEQF+&-SAO2^Y!/"$E*Z% M2V*_(*_2HQ9^@[('+(]/L.>"1XA["7(< /\\3N,@SO@]R67 M +\F!936+]RKU&AD?R $'J&>BQPAZB6P<8!ZU9WU?4)W*!==;MY"-R7QX-I& MI8@0HMCI_>>-%"3Y1S.+-S"'Z EJ(9G#Y [5/ W$J[J& M&M3DTUYGK UT'366]SEN.@\AQB- )9U'N!=B26@#"B#9?)@)#Q9)H2_^V,;% MCJ31\#IY;DNO!O 1 R<">#OQ.*#U(>&B-"/MNCO9P6'QK MHBO+6;8.8J9$KOU0 )_>_KL2 KE5& *_EZ0>@$C:]::]S%5\$: M*OQ/E\PZ1'I2LM?B!BD@?_?&J_"ZM8\#<9_:'WZEL^@3.H. T#VT0."-7^!W MKP@(;CW!X$* \NKEY:JZ>VI;/.*%TC_E3TJ._ZV74W4DZ:\)ZHK*KS47P^5@ M_T'W]C$9YD:K0K]<5N<4X)V4X1(6<9EG:?S_- M\N(J*_X3%C1R'JZ>D\!I&"ZS:J@Y&K#(&6,%^Q_Y"BW)HCT8"X/8\R3VCCU6,JC'Z+ M9_*CK'Q/MP'K%JRM6=_R&D:AR8&*V;VIF U?'^)#QL[J+>39&MX%SX9'&25< M+NX-E^C N1"F<996P^8$M^EI$++F\.,YHI M_7T MZ?2]*^CH>%,AAV/PR-P.@QYO#DP9Z+ XN?,-ZTIOJ046NVB_2+'%T4MJ5">< MN-1.4,[*+#L]=YFE#T=X]EX#BOL]<^[/B2?)2/ P)!T&5_A1;,KSB!VC1[!! MWX.)-]OTXNZ68\3EEOUEG,+EZA3!*"[.@S!.XF*G (J8Q3I<)-+W07,)TP@B MO^HZ5)W?AXU>S[OR+UJ5'V(6Q[Y&6@W2\S@SWRI#5 ,A]S_NJT6Z\I29ZSBL M=LZUT<3P.884JX<25S5+77+($^;%35! 6H=+ M]DU"_(?@03_6EC?B&(4*#960K/D!:8 4 = ]BWT;OF%39T3E0-4?S@.N'6X2 M0%4$IHRZ10SN]@/ZDDO T9!Z M$WK+^U^819=TODOL*,-N,8L'^!&&W7P$>1-UJ\9!C2*W43>6I%Q+G@8([589 M(L4E"C^./E&/1!Y/F0#A&DU9.0,GI![*D&0(! MOKS+%&B.DA;:W.<-L%CEJE+MM=IT+O#4D9.'GJI,TB.'Q'8M!Q:B?G4 AU' MTZ5T!P2I(ZFAX)/7X'6Q$ YNO<(-.8:C\ @M&NL@:,O'7FR&_^:-$V!ZLC_B M@FYTNW]5;O4HO8&:U8O]K)XVS+X6N>\Q6]7!1\TU ]6&ES].1'>H=':]Q.-T M0$KN;]N4/(M39.E)D'[^!,E9/5%BCD]K-STGD+>/D#T9('3@]Y+2=:I.UMN= MA)VZJ^VYFU]2U!RPP+/="4SA*BYD$XV0P[IS$1TR;DF9?:MH9_NDA3E/R M_--)@'DF>QE:XT53<[TJD4%0@/M&#^P[=S! KEX:/4@+[ 7E\MOT[PK;Z+MU M+<-PM2V(YQDX7V=;@]WG-HOC+;^.],H-/D(-2G+W(%(-@WSG3C0&]F"TQ 8? MD.GJ,LOS=K)$-D?(F*Q#2:H!<[=;30P(=2?UY<$);+5 @JZZ#5H7 V@KOB%4;V3EB#495K=IGT_! M<[S>KD\RA+(OV,9.@PW^2[$S3 &)F_$B'2314CLU5+4!FD9 W8I[! \969V, MD=ZPND&P)D(=(U Z3W>QYA>,=&#B"@;G<8H7\W&0:)_3$7)8!X=8=LX5_B6E MC\=V%$/01XU6_]N,Y5#\A)]I*Q.8C5I%JPL5E-[B.@=(:$ M#;ITQ\/BQCH*TGP%43Y/H_)Z(CQO+E<< \COL"PY_T_J7?E1/V-_2W_<7M)Q MG;E'NWI3@(2I*Y@,(7;7W#7YEJ3UR55>JD6W M03M.5MTF>G*7W54#8-\"($V ((VJ0^)5*_36.<6;4_8%6&G*UXEI ] M7/;(1_<.8#RS8/981K8)B_?BKE8P+!J!L9PD$4KNUTQ)DJF\!1P[N BB("$G M![?DN: .L<17C-*Z_1ML1^D3YEK:NE70.@-$$^W=EF>D"J)J'#2M]YEF]7%5 MM\YDFJZJM<\;[2LG4F#M$>9Q[TM&M!OF^MRQC<:U-SG-2+7;EBQPRKUHQ0WZ M!HUXXAL$&@YW 95Q>_ Y$@*OQ #ED%5ST[5.+6\#KB!)%T0%EM$MH@42W$A MAYN(G2L[/_;LD/JRY%0, #>,5/6^Q?V\+'VX@VA-UK6G6X3D%]=PJ>WO[G%E M5A7C5)3@4T"ZO1"^8GNXR]6YT5=3!YCG'QO)-QD2/T%@*QK4$[PG,ED?)\UX M1)C5O=U*D,_LN*I@;_%%@C7IT7\&96%+E2]6^WPYF_W7!^1:,&\.M,@)E+S+ MI1ZBSW(%&@9?YC0=E#'/)6A#S**UY#DL4!@$"Q&@<47*+?W.?QCBR58D'>[R<:@ZEEL$8?]UR"% MLC,7*3>4@)("0NM-)81B#)AW%74&P$5I#5FGDL0SD4CCBE,9F\/2&JX6DM*: MFMZC:@.=(1&7UJC&P^857JTK!K\$&^%A8Q6#@^N[!)*SEW>U[HT$A-2#D\=Z M_<]>W*7N?%>G-R[C%%X4<*U_4*/%X?A,1EMVY27OA!A0:@_PHQ@#^9$*P0 X M#8V4LYJ$QX?P2#B?"0(D;V8TY5AH!$E^S&75.WX$ZQH368?:V2S6E5DXA55D M,YHP<8\928^+IBYA=UN\EJF?JY^G$?X=1$]09Q+38[=_F9.>5LP]3\P.#"UN MK#@]F^U,1HZY(Y&R5__.[XAY\ I$P>E".K <>L MDS319G$3+0RS\BZ[TT=R;R8Y!K% *$.G&3;FD%8_:9B163/VM^#,M&1VZ!IV M4/'3P)BV %I->/6D[I"193;-!@^K/01?P2][,:]1EN(?0TA/UV%I*[DOTC9- MG(;Q)H&YSEN]XS1O'?$C]4K?$G"SH&4-W8:I4=0&$J==PKIUCQX.GJJ/%K^! M^>GI\I>KNXNKG\'US?(*_WRZ^+2XNO/@Q?8Q[:7O+\8WE@.NSJW>=",G;S-T M#P-$5F7G4/BNE9C>[A6Z$KG[4*M)2=U4BY@<3)W(M*(LI/L%=%4[@@9WCQ $ M].(QHL.JI<,*0K )X@A$93X*+S5 >7/I&\>W!*N U;DI6 ]5-N_X">[)Y4,Q MGT[,2:/"GD/LTF0DM>E[(B\*$[6$[E8GMJS"*]BKRM$5&#D@(#J/45X^ M))K"@MQ;OUQ=I%$% $9#5 G MP# ;'=OEV;*<447@J"";E^>1Y.!M+4J%PEU$V!?$J_)^5]EN@1V/+)2S],*^ M;&=T4<@O"G?Z)I2RRK)#Y>9=**%;K5Z&\F:SEM.CW->AAGI&P<0ZCZ*8K(># MI+O&PWX8WA7^.EK&B"U>>W.]$:Z,6XTH:UGY@@K[?OV0'A=YFK.$!' M5>YB1UUUO**I"](:B'. ($UJ!#E)9M"_! \(TAR9Z[R&*8P[8<@P#%O<'2:+ M8BPIO?:+U)V5UW @1/P!Z?V3W9ZD2MK,R2L+YT&,?@V2+<23Q79-+QW/2>5: MB)4BYT:/9;O+$W[4_N[TE#W(W?@]HDV!]N= ZWO@?@?:=-4WP;Q\Y99\%M#O M@M:'9Z#^-"#?=KP7;K-+&[V3>$7OQ2;.)RMYP2OR7E/^VOT4/KV=,IOREHST M@ "CN: $YI>2LE0)K=W 02 O6\M<7Z)#]@4O?2@O579W9])3][7%"2Z$:8#B M[!IWL7)1P2.V/Z'P)&8F@HIH!@B9!YD:=7\S#D;1V:88R6'XYB%[>AO!F,#C M>_(#0<7W+53@7_WCK(I_+U($Y^B.Q8U M;LP&XH!IY>Y+=O>8;?,@C1;QPV,!85KNIF"_1I)-3U#J3 :T87<:,M2/6=]] MR4#-#^H&ZBK+I@D=OS1U/#F&M@0>@Y2S-BT/@6MGNAZ.59NO^0;E72NP&UL[5U;<]PX=GY/5?Z# MXGVVK6Y=6CTUDRU=+$<565))FIELI5(HBD1+W&&36I"4K4WEO^> ?1'9C2N) M;AYR]#0>&T#C.]\!")P;?O[KCVFT\T)9&B;Q+Q\&GW8_[-#83X(P?OSEPZ_W MYQ^//NS\]=__]5]^_K>/'W>^TI@R+Z/!SL/KSIF7>??,\_](%_UW!I\&G\8[ M_ ]['[]YKQ^'NX.CG?_>'?PT//AI;_ _._][_.W_=K[]\W/G^_?NG $;( MBA$^^,JRYY\^?^;M?SRPZ%/"'C\/=W?W M/B\:?IBU_.E'&E9:?]];M!U\_J]OEW?^$YUZ'\,XS;S8?^O%AQ'U&XS'X\_% MOT+3-/PI+?I?)KZ7%:+2SFM'VH+_W\=%LX_\KSX.AA_W!I]^I,$'D,'.SL\L MB>@MG>P4$_@I>WVFOWQ(P^ESQ"=>_-T3HY-?/L (82'FW;U9_[^<)7X^I7%V M' =?XBS,7B_B2<*FQ:P_[/!Q?[V]J$R?CQ'[G(+/_)\_JT?X#!-L.,6[+/$+ M[,%I,GVF<6HQ.5E?!].Z +V?TLLD36\HNWORDJB?D^F\ D)"VEJ.H]2 M!QN!M;Z(^KGC)Y[[X>Y/$H='$S@C#YDABNH:.G@)X]]G^4T^/*#:[HI M[K5.#B9R1;_#L$D.^T'\>,.2&/[H4TZSX:24 SB8X&D2!QPN; MQFD1AP#]3 M)U[$]_J[)TI-YVDRSL:VP'OO(3)E63W"1K9#F^G)>[O=&NWFM-9M(]ND%8W2 MWAO3LC.:>6'42,V60VQZD@,'LQQL?IKW]$>6>Y&#R2Y'VL@*MJ)>T7TK&_8- M_&*X.BM'T=W1^:[.K$3]W)_] MZLQ,,\2F5O$=7.MG1[OKR?4SMQB &J5PG>3[':-/T"%\H3,R&ZQKNY_9!MA3 M+WTZCY+O3'';AA-X6=M# 4V RX! M/)?^^A+F6T$"JDE!*,$""_^=^L:*PI8"/QDE?N57(F[%29A.8/QOB.H'CA]2 M;K_*%@-%W@.-BN&)<5\R?).-Z53G\BBL2BGU/STF+Y\#&GZ&V>_S/W 8^Q]W M!W.;TE_@KY9S63UI"N:N:D[V*M,MDWG,JE/WF+\8'/ZXQF35)C9O\?FY^#Y_ M])_":*D$$Y9,:TAU/I?$#%2>PO220IGYWIBP@+)?/L#9$2!.*&,TN)Q)2 JA MF'\AQF:,3KSTH1@U3S\^>MXSIW7TF499NO@;SN^HQ._\K\ER[SB-O!168''2 M//X1I@*2M7W(8#C>;9-L'6-5?DWQB'D>=HKG,K2S9.J%L8+@]<9<$H,VF37E M2LRP%)"8VKT6J&VP*<,GD5Z 5$1K5M>%['=GO9I@$1.ZWP%"[V%8#8&\"3E M2%B% CEIB_F+23I 3-(Q3#_@$,XC[U'"4J4-.>P>36L Q#P=(N9I ?J&LC"! MLUYP!I\+S:JJM"6C[O$F!2+F;]0!_L[#U/>BOU&/G=R14P8B['B+F$01$2"85M6&U,*3S- M&:M\&M3G&EESN/)VCT@E& F7;5AF[);C>1A1=@HP'A.F7HR5EF30JBFUR5)< MQR$A#[/MY9YY/,KU[G7ZD$02VBIMR "C>45#V#H""568K2KS#T RG29Q8?8K MHA'2ZSSCP;P3\EQN:<0=MJ=)FJ4% <5L;[S7PGNK\ VZ&9@>' "L_K#A4S$(X-06EW/+JD5>S^<",B1LS.C+*67;>P.@IC[%G:&+QZ+ M8;-=SL%@SY'!\V-:B$4S+9-VHN@&<5AT6QA(7KQX]M,XO($%J4POK:#Z+ M6_J<,)Y.8["(9%W(_LJEMD48=@O)H#> 0W$85 M?O)B,X3E:4R^4/22M'N9F MB7JM?);F/V_Y69+V(D?M+2K!M,P^2_)N ?%,M)*7/99TD'K_&>IR#=MPS+" M,Q]L%HVX SD:CEJS9%1F9&2A$/< $*U&*IB(6&)14 'JP>=E-1^ZA85RX[T6 M69W'<5#,QHM,[(.*7F1OQ?^W13#S/.YT/KW%[$ 30N\AC,*,9[19+:F:(X(0 M6G6A&?,D7G>-4/=@7:I* K2P1M_F3\S"&N81>=).DH2;CSZ8[&0Y:L[HLIB?+_A,W),-6XXVLA2NQ MJJQC>L_[6\V]&J(X5 FHTG J!/*>[A>38:MQ2V8\B;F5@,&3Z.=@S5XJ$O[D MC#)\&MP<4A3:A3O4VU(AJUFE6F(D5Q9UQ$X2O];/X:V1>0\ M2-F8SY7V9(C"ARM@2D6I"(2CA$$,S/)"*OQ^!?_Y\H\\?/&BXL:5G7J,O<(M MZSB<$I-6DT!NLJ,Q+"VEU%I("&3N#QH1O90V+IL=^XU M"*ZR(U<#&UKPGS+Z[(4+%ZY^9Q:V)WLH#%NVM,JQN,J8Q+!,*U(QO7.1/126 M+>LCUAH&5^F369)Y4"%+[1T'DEB7[N8]9W)8'"(Z&-LP+XQ)E?9F1BTX&P^ MX66LY4QSG(7Q(_P/92\&="MZ\2LEB@M3+=;UP"3D6]O',)"_GN1AM-+% M?9LD4KB+!"P]M-R!=D%K,A@>=G>IRP%)2.ZDHB5HA%PJNU<:W],/#C( AG,&Z\,+B(YZ=1E6%-W(,3U6F-X(@BKL6V!(V$76O+6OLGA$8WM< MV\_^%-5%6BD&AO?QG]:>"[GSGVB01S#OMW=FR@@*"J^?9T7Q_"Q\ >TL"#0J MZ]YXRPH"X3?BV:JD*;Y=/9WC;2S M_@\!"RC"-+>KJ4WEY:BB&Z:WJ]K[O#E]P6HEX+R5#6!U=J!RH0\'IK,PRD&7 M:ZQTJQ%!""B6M)HDW6*M ;D'U6A+KV.UMR W\496:R6FWS1J.<%Y]$"-=:@> M@HQV4=ASM$SHUIX)S!XLMO67M-I;O\'RV/NS8CDH,! MBAJ(:I*T)U9[R'U8ET+[RQDW.$?O!IC2K>=PO[77E]]T=%%VH#S_8\;X*P)\ MMK^'V=-%'(0O89![D>!58%T)>*<_!")#X5EU0;QN\W GKS[4IR_N^O?P*YJ: M])5V !^'DW8#I$H\N^OP^U"^7FRD+ DNA>^IT#ST)I XX-64KKPIU1; W\3/ MD4, !A2!U&[5JN;7N9[P'#W8\$Q9F 1WF<>R]D.^+M(TI\%941KB M9C8Q+IFT[#G\\H,R/TS?K!RRD#"KP4"F*.X?6U'(FM)I^B+$>*9Q,7WD-^_[ M]@,)&B[,K] P2R_BF?B^LB15ONKD_M?(X2&*PV@7=E&I^!R];!'021@7H=I? M\S#@-2^ZJM;G"9O0,,L978IK@VHM^#7@!<7IM@MJ+15?T[JU=*9N?=+W'0%VW^G8:/3[!$CU\H\Q[IXLQVPT)?Z>W9S@S(X0A' M?&ZW-%\O4E?/O:"Y_]4V:*Y<5I;?P4TM#*<3 3+?OPP;E&R?7LUI++_J':BM M]6$^"Z 01>)])Q:'K5A=O4+4BY4AN$:UM3PLIP)DXHBSZ<(:J27;/CW@]">Z M=QRAB.% L2Q]]P&T M)557SW@UOV-O2-N7#C[)UW![.F\_$]B.>G]S;E6T?7H0S:WWL,XJ:6DFY'#\ M[DO;I&AQO"WW?AI:4-+[RW!+0G7U*I_HW(\DX6WPGO%62GP:#%K[6&LJWI@8 M?,R3W1K^!@@*115H%W1+/JMN1?4G3G$;H/!F..93K#0"Y._9;4BRVW#DZPLT MQ+757R>$]^RVM62N 8KS\^8H%ZN81B!]R&ZK?6.X-,AK:SXX"!I%_L56/HZN MQ/6G3F-;WD]+%01OP_2/#)[;DV@<;%/I1;\-;*$P.7=(Z>5B;)ISUW>E_RV) M8)@HS%[;4/OJKY/!\ B%+:B#FB^4I*/4/#3*OV9X7A?:@XW0^+-\ YW.;^1' M87-"X7S?@J9O4'Y-<_2P5Q#D!1-S0/;N5EG:V4?[A^]N%9/K\Z@7Y0,+NC?M M5AGUI7+@'=!; )X]9DD TGTP0VS@D[K1Q&V M)R,<9?X,.)-8K>6H^N#9J.=D'>%X?7TKJUV _$_AJNB DW6$HT"?0$.VZ&0= M]:76GELGZPC'N_&;H]S6R3J2OSEO;=YO54\6PM!\L3=5+4Y)5G[\A"6Y,^2=3[_??D_BG)4R\.OA2QS32>'94O M8A_D$;Y0#D6Z@5N/00;#,8I#IXBA*I=UL6W,4HGP=-ER(,SH$,?I8"OF"D?B MU1R:,69FT.5'I<9X])2S\I[I KNO?(J,1BJA25QKE6%_58G-5RPO' M'8FRE]"G8E%=)?$+37FV$9=*>L]?'B__.[>G7R79WVAV2_WD,>8R*E?JI^K/,E'/$S;_*]Y.Y?#?[D2 012E)SJZ&!0R M=56;JUW[?50,3@.QR'@\1)RJG,EF X#$XG.4 M;A],'[;N5]>&;U0:PI11K"RU2#6.\!*27H5(G$9>FL*%@I^H3,,C5ON 6'!$ M\0G(TM JAM*'V(8R,JU%>;TQ" )'EK&:*3&],CA]"&=8"L3(CKC6& 2!P\!B MOU97,/0A1&'UDP0'LM"O<3JH]".'![B6[@IQDON1'I*C$ ,WH,KFKV=4(]? MX&#*E\%] H?Q:1(7&]=3$@&^M)"#0A4L1P))HEC_!G2+]:06WA[E_*W46:I: MA$OUF'1Z8S4.2!%%=$%MK:F!UE%(0=;ZDT="H=E^7,CA(0J+=6T-4*!R%'V MC^FS,,JYTML?*%9Z@IQ01"8T.U((0?4H),'\TSB7A)-CQ7PLD"9**X^0]*9' MBPIF5U$#&;?V_QG/%H"Q4*82[$-4D@_ M3@U')H7I@IF*P%7/O+VSSFP2[/B&%!X1_G>/(N'R3(6/N398M>.05HI MH+V>W"P %INX0M4:C@R"1N'*=J(O8E5T(J$^/1IE))!UEVTI[K&I/BH'!X&C M.)>UK9(&0NK3"TV2(XE,X/:'.=E(($J4!L;FQSDU8EB4QN#N8="-+4/)F'U4@=91V+JJ$LA!M#]:ZJS)$:[\=5Q'TH9@&#V7_S@^JYPD[2_*';))' MQ[Z?Y'"?OZ4^#5^X;$YSQ@6J20\P'H?@,"5+:!7K@#W 7M30J.QB%CFMZHX$ MAX'72@$,$/6B?D8%YE4"5U?=*YJR+F2$-MS!D.45+.T6V-CBDKT.*)'UH@!$*=K*Z!LN;$]&N RD)D3+@?2BND$)GL5I7-&+ MX' TUN58"*<7&?MK(+6G-$D/,L)E*ZW%< G*!C+J$;!K=CI3=2,X_,3->%[% MXRH@H*7R"2\P6,+MP2W635C,XO7M^00#EZ^B%QGMMO8<^7):O_?0-]9Z$5&M);;@SA0'%%E1&EH M78?2HUH*2Y2_)^R/B_B&)3Y-C1BN=""C 0K77DV*!5AZ5/5@"?,\C,/TB09? MDR0PXKC2 >2"Z_ALQ[$ 2X\>]EW"_,H2L_5;- 0YX#HGVW%:PN"J#D'K&01+ M<-R$/7_G,*7LA1JQNM8)I(/K6&7'L 1/4V?M>,9V3!^Y,P@'WU?4R# #S4 & M*#PT-3E=(MA4\O\6G]ZEC_P*>!%/$C8M/[O;2K;';#*W]#EA&4\$-,CPD'0A M^RM']FW">'OU8F5V)3&?O,[_T>(U7-/1R/X 1Z"BDAR)_:@NW'<3XJH99Q_' ME:8VH[8&QGWYM>?/96#O,-S4YSIO_#2U MJ!^(!\4-:%/+7(ZY#_;).2K]^[+E=N1@#U=HA)PC";GK:-I-2I$\ CA_KF.! M2_W:G[ Q@$-A.A9(O$J-#@(*E3$ M]/J9,F\FD44I3@6M@M8@$126Q:8,2Z&Y,CEB8/LBSBC0D^E?\5II":+ L6\W M9%D(JW$>1]4W<-]ZP<;K[(FRJR1.JCJM9UW=$:2%Z6A=?ZD;H'25 X)CU2]V MM'.0Y6D2 ^8<8,^WO"1.3RA(D,[:W7L_:/HMC!-6O"T^6R_'<5 =9?;T^#>: M/27!1?&*HD%MQ6W- LC'=+EHL%MM662;*Q2Z[:<("V',/6OW,$;>3CFUY60L M0^JEO.3L&K_\'9E+3-"*C/=0!--J922XQHN0],&+M<0U3V_+7C7V;7$' M$$BKES4I1ZK=40RB#TZI=7Q:H[6L"P@%Q25-19DIR65$??!1 ;93F&B8G7J, MO<+GG+\NK%F_TCYDO-^J)])R"6MP],'?)(1XY4VI=C%K>H*(4+@A-1Q:$+^* MK0]ETP#H[,5X_8I^:P?P6]VN[5?QZMS[4-)L"MAF]9KKJ5>??"L<0A: MAPIBRYB4.Y_&'NPBIK%5Y?9<'JV:%2P7GPI$+RJ$+7#]&J?/U \G(=5_!J5] M0#!'*.Z?*MHD1&LP]:(&V +D3>3%^BK<:XVY*% <>'1DJ2E> ]1R'3"=T9:F MEXJH'&E;#JX+9CX=@%[4[OHU9M1/'F->D0Q0GM"83D*E&TW2 \X=B*Z,ZVR) MEYX23"_*=RW#2KC_K6SL, JS6>M$QH>([BBF-.OP;*!V5POO>$TFU,_"ES=O M["T<-FY!OV,_C,(90]DY!6Q>Q \B.<]LK#16J(2#T=PA=_6 M&$(U$\4&6&N3:! NNE;-S"Z51@%0HAM-S%W;"WDXHP]9^[$.Q2QLPAS$';$KV-#F<'['SD_8S]F M27SBQ?(W':5M 1J*W=B, H')4@ZJW: ("5_G(4NS(EH\IAF?\?7D(@Y"+_;4 MW.GZ<:\*BFHHM8DT1-B'. DW/MSQ 8JL"\N/K )+'V(JW#IRQ\A>]5KGS-:- M.Y:[[+L5A[%\$M[XHBOI 2)!\06V7,=*-+V(R;AG7IS"9-/C.)@5#N&6S(D M>'H/+\)1%%C%W MGMU]]YZUP6'B#EPD2(X46M[$A"MQ]2)0Y2Y_2.D_7"A= M-.VHX6P@Y*-MCF=97*%_X[WR_S5F>J4?&>.HVJ;FSX1S(3 )\=VRZU5Q5LXG MQ7/E@-SGE#V:1["H!@')H0CQ;ZX2>I02_>B6.; *^MSSZ?$TR2WVA+A_M53))(F&Z9!:L0B_!J_O2#'=O5;F1\V),/@ B7A/6NV>'*,,]HZK.P M@'0]^F6\4[D_/[F_0BG^?0D M82SY#DOCU'N&?\E>+6-M9,. ]#I[4K#'*=&2;IGYRK -M8",1PAOA/8LSW!( M6.R6!8^+XI9&_$1[FDRG85'8\9Q2[L JQ)2FN1?[]#1)E1F&5N.0\1$22WZ] M;X(E4(FB=/(A7S@2L2S\IS?["LZ=E["_:=1#U8T,=L,K(AC031!+:MF74D]!V', 9HYA2==(7<0#X:<#?<+KQPD!&HVE_'HO: M35HM$4IH[I9M[M?8FWUK:.6&*(PEUDQ*%$*-LP_I MQ4T?!-X;X@B-43,EIE<&IP\YQ9MY$'AOB,(&YGIYR['V(?6XWD/ <+M#0;6> M(PFYZVCZ4&:]HO!&N0N MF73GXNK3I]X"G.SAR&VRH,Z ^PHX5_G(& [XQ5OM:[)2 M%L\7]R"#71S1ZXV)5P/L1:*R2+=/<\;4.8V*7F0PQ%%6<"/+O@IR [G+VPN2 M.$V@>9SR#V"<)E$8\(_A\G:47D_>*K>#Y$Z3*?S\$W18EGIO[Y7WY2R-7WA? MZT%6@JG;L*1HPR J#SFH$TO:*J@X"D!T'RH**8*@FO"BB.8@PRRMIV.)5 ?DV2P(+>17-RA,*S M6)O;"@Y'L0*XB#7GM! #BE#?VG0N(#@* #(78^,RV4]96I!ZTHG M,L81<5N381$:5R[[]C?@KRQ)TQN63)35)$JM"(ZT-2LV5Z?ORNG>/GW+UWH7 MF6H&]DQI'X*C'H 5M6HPKGSM&';E.QI%;SB50?#EAF2,PHRDYDER\ET'XLHS MCH%0[A "(3X5%4Q>:)0\4-1W0N MFSD[+^'\:<+M6VN"I#!_OUVL#SBQ5$?Y\H^N,8OEESD**9D:GS4H[$ .*ZZ(5I0($KBJ M[]:B\^P(%B68P4M MON&%UX":+&/A0Y[Q^)W[Y*:0\4!W7JDW*C_U=6_9-P?_B[RQ6,QG([2&\KNGD"2_+$$7T&UL#T(I7MW M5@62/E4$7X5Y%D9Y1E4>>DD/$$WW/+I*+'VJ_/T[#1^?>!E(F(SW2*]R7AKD M>E* 3J_S+,V\..#9J'J_K^U0/+6ITV2C02B1''=V((NJ47@JGXZ!FU27<<69_#9 Z#P M]XQZ_)F'V7]-(IH:#PY7ONX%^KN"[:I2^[J>(I&!OOCMA9SW?SCP0&*B 6]6,7K383F/0]Y-2UT<(#+,%0B2T.K&,I[ M*G(,@L!E!Q(S)3'Z2>"\9R-SL>$R_9BOU14,?4A(AB,;_QS=L.0EA*//R>NO M<)RYB)=!559OO=@/!H+$:NXI*):Z FOA=)3DC.%J5=/O>X#"8%.7/R/'\('4 M)-/!I.?CX._Y/$#E/KFE?A+[840KB.\3=QO()GX.&$%AV7&K=)N3E*,T;PR; MU!F%.?OAC.DX*+_?JE!"12^0$(K E(.(!44IKUM*XI*&HZ2U=O7D4)6*< X3]A9DC]DDSPZ]OTD5P?;JKJ1P2$* M \:V]44O$U=9[QB^1U^],.8BO(YY?97K": 'L66O-Y$79SPNN$@^5*B0V0 @ M.!0FSVTKDXUT&F?C(XJS6W6TE 1XZCV'F1>9%1PU' 0$B,* LVWULI50G^H MK&-?[-(@>!J^:%PR)MU!:"A,0;8TFRJ+#''CZ@*H=R*>X1+#KX7*/&-E/Q 3 M"JO1IA1C#6KCB@/(-6*9*W7CO?)U4(0-E/ZZYI9B,S (&H51:',Z92N+/I4X M6)?'#://7ABN-#?C&-2(0[3?F8G3R@0(!HK EN]4> M6_S]J3@A07X>QG O<'3.40P&XD1A1G9RSM'B[%,EBUOZ//]47T\ND_CQGK+I M&7U0OQXK[@+"06'FK4NK6$G4:!M7N\!T=%GBY/@NTC3G-@7=*]**7B B% 8Z MMPJA!=RXG@4BG:AH/^RI/)<7YJ^L7RCM0P8XWL#=X :Q#K=Q50I$VE ^G9MJ M@[0/B ?S!:;N[J"&VZ>J$I6[&D_PO"YPI5]^4.:'J;(!%?1^+B/ H%LAD&1(@B?L7. M(&*/4*(DUB98K$IR#&N&L5=8'K]Y46ZO'2O]06@H;L0NU$((3:(/UA;5YT+G M8)HL^S-H!=H7E9MKA?RIY3UK@^E,*[[$[9Y&[O+GYZB0DQ$ M&906,QL!A() <,@Z"U,_2M*MQ]KH[KF-7OTXGD- MC+?RG[/Z&.6Y74_F%'O16V50D_*R+L8GPY7G.KLBH+5+CS>?GSQP<[!^T8.S_ 5!+ 0(4 Q0 ( '." MKTPMQ_@%KF *-H!@ 1 " 0 !B87-I+3(P,3@P,S,Q M+GAM;%!+ 0(4 Q0 ( '."KTQ>Z(,TZP@ $Q* 1 " M =U@ !B87-I+3(P,3@P,S,Q+GAS9%!+ 0(4 Q0 ( '."KTQX_G#]L0H M .*9 5 " ?=I !B87-I+3(P,3@P,S,Q7V-A;"YX;6Q0 M2P$"% ,4 " !S@J],3I/_WE8C "L.P( %0 @ ';= M8F%S:2TR,#$X,#,S,5]D968N>&UL4$L! A0#% @